Processing 00000000.tx.1: Serum Transferrin Receptor and Transferrin Receptor-Ferritin Index Identify Healthy Subjects With Subclinical Iron Deficits By Pauli Suominen, Kari Punnonen, Allan Rajamki, and Kerttu Irjala From the Central Laboratory, Department of Clinical Chemistry and Department of Hematology, Turku University Central Hospital, Turku, Finland.  

Phrase: "Serum Transferrin Receptor"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Transferrin Receptor-Ferritin Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0918012:Index [Intellectual Product]
   812   C1552854:index [Idea or Concept]
   812   C1637833:% index [Quantitative Concept]

Phrase: "Identify"

Phrase: "Healthy Subjects With Subclinical Iron Deficits"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1708335:HEALTHY SUBJECTS [Population Group]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "By Pauli Suominen,"

Phrase: "Kari Punnonen,"

Phrase: "Allan Rajamki,"

Phrase: "and"

Phrase: "Kerttu Irjala From the Central Laboratory,"

Phrase: "Department of Clinical Chemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Department of Hematology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587491:Haematology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Turku University Central Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   875   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "Turku,"

Phrase: "Finland."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]
Processing 00000000.tx.2: ABSTRACT Abstract Introduction Methods Results Discussion References Despite the established utility of serum transferrin receptor (sTfR), serum ferritin, and the sTfR/log ferritin ratio (TfR-F Index) in the diagnosis of iron deficiency (ID) anemia, the numeric values of these parameters, which are indicative of subclinical ID, remain to be clearly defined. 

Phrase: "ABSTRACT Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "References Despite the established utility of serum transferrin receptor (sTfR),"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   764   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C0428545:Serum transferrin [Laboratory Procedure]
   764   C1318186:serum transferrin [Laboratory or Test Result]
   764   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   764   C1619635:Transferrin Receptor [Immunologic Factor]
   742   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0229671:Serum [Body Substance]
   742   C0443211:Established [Qualitative Concept]
   742   C0582205:utility [Organization]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1272684:Established [Qualitative Concept]
   742   C1442762:TRANSFERRIN [Gene or Genome]
   742   C1514811:Reference [Idea or Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C1706462:Reference [Conceptual Entity]

Phrase: "serum ferritin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0696113:Serum ferritin [Laboratory Procedure]
   861   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "the sTfR/log ferritin ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0456603:Ratio [Quantitative Concept]
   799   C1547037:Ratio [Intellectual Product]
   709   C0696113:Serum ferritin [Laboratory Procedure]

Phrase: "(TfR-F Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: ")"

Phrase: "in the diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "of iron deficiency (ID) anemia,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   901   C0041782:Deficiency Anemia [Disease or Syndrome]
   901   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0002871:Anaemia [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1000483:Anemia [Plant]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C0857322:anaemic [Finding]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "the numeric values of these parameters,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C2825553:Numeric Value [Quantitative Concept]
   753   C0042295:Values [Qualitative Concept]
   750   C0549193:Parameter Value [Spatial Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "indicative of subclinical ID,"

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "clearly"

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.3: In this study, 65apparently healthy nonanemic adults (22men and 43women) were treated with 3months of oral iron supplementation to evaluate its effect on parameters reflecting iron status and to determine the prevalence of subclinical iron deficiency in apparently healthy adults. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "65apparently healthy nonanemic adults"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   858   C0686750:Healthy adult [Finding]
   812   C0001675:Adults [Age Group]
   779 E C1706450:Adult [Human]

Phrase: "(22men"

Phrase: "and"

Phrase: "43women"

Phrase: ")"

Phrase: "were"

Phrase: "treated with 3months of oral iron supplementation to"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   744   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   744   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0376520:Iron [Inorganic Chemical]
   744   C0442027:Oral [Spatial Concept]
   744   C1166521:iron [Pharmacologic Substance]
   744   C1522326:Treated [Functional Concept]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "its effect on parameters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "iron status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the prevalence of subclinical iron deficiency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033105:Prevalence [Quantitative Concept]
   753   C0220900:prevalence [Quantitative Concept]

Phrase: "in apparently healthy adults."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C0686750:Healthy adult [Finding]
   827   C0001675:Adults [Age Group]
   793 E C1706450:Adult [Human]
Processing 00000000.tx.4: Significant supplementation-induced changes were observed in sTfR, ferritin, and TfR-F Index values in women, whereas in men, none of the studied parameters showed any significant change. 

Phrase: "Significant supplementation-induced changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0392747:changes [Functional Concept]
   812   C0443172:changes [Quantitative Concept]
   779 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "observed in sTfR,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C0428545:Serum transferrin [Laboratory Procedure]
   806   C1318186:serum transferrin [Laboratory or Test Result]
   806   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   806   C1619635:Transferrin Receptor [Immunologic Factor]
   760   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0229671:Serum [Body Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1441672:Observed [Functional Concept]
   760   C1442762:TRANSFERRIN [Gene or Genome]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]

Phrase: "ferritin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "TfR-F Index values in women,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   756   C1881192:Index Value [Quantitative Concept]
   753   C0042295:Values [Qualitative Concept]
   753   C0918012:Index [Intellectual Product]
   753   C1552854:index [Idea or Concept]
   753   C1637833:% index [Quantitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "whereas in men,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0025266:Men [Population Group]
   756 E C0024554:MAN [Finding]
   756 E C0086418:Man [Human]

Phrase: "none of the studied parameters"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0449381:Parameters [Finding]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   726 E C0549193:Parameter [Spatial Concept]
   726 E C1704769:Parameter [Conceptual Entity]
   726 E C2350001:Parameter [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "any significant change."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.5: Iron-deficient erythropoiesis (IDE) was not observed in men, but was found in 17women (40%). 

Phrase: "Iron-deficient erythropoiesis (IDE)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014819:Erythropoiesis [Cell Function,Organ or Tissue Function]
   755 E C0312829:Erythropoietic [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in men,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0025266:Men [Population Group]
   790   C1441672:Observed [Functional Concept]
   756 E C0024554:MAN [Finding]
   756 E C0086418:Man [Human]

Phrase: "but"

Phrase: "was"

Phrase: "found in 17women"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "(40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.6: Although individuals with a compromised iron status may be represented in substantial numbers in conventional reference populations, they can be readily identified using sTfR, ferritin, and TfR-F Index determinations.  

Phrase: "Although"

Phrase: "individuals with a compromised iron status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]

Phrase: "may"

Phrase: "be"

Phrase: "represented in substantial numbers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]
   737   C1882932:Represent [Activity]

Phrase: "in conventional reference populations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "they"

Phrase: "can"

Phrase: "be"

Phrase: "readily"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "sTfR,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ferritin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "TfR-F Index determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0680730:determinations [Governmental or Regulatory Activity]
   779 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.7: 1998by The American Society of Hematology.  

Phrase: "1998by"

Phrase: "The American Society of Hematology."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1515949:American Society of Hematology [Professional Society]
   812   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   812   C0037455:society [Organization]
   812   C0200627:HEMATOLOGY [Laboratory Procedure]
   812   C0596070:American [Population Group]
   741 E C0205488:Haematologic [Functional Concept]
Processing 00000000.tx.8: INTRODUCTION Abstract Introduction Methods Results Discussion References IRON DEFICIENCY (ID) is generally acknowledged to be the single most common nutritional deficiency worldwide. 

Phrase: "INTRODUCTION Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "IRON DEFICIENCY"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0240066:Iron deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "(ID"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0240066:Iron deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "generally"

Phrase: "acknowledged"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the single most common nutritional deficiency worldwide."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0162429:Nutritional Deficiency [Disease or Syndrome]
           Deficiency
   799   C0011155:Deficiency [Functional Concept]
   799   C1521739:Nutritional [Qualitative Concept]
   799   C1623416:deficiency [Qualitative Concept]
   799   C2707262:Nutritional [Clinical Attribute]
   727 E C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.9: In developed countries, the prevalence of iron deficiency anemia (IDA) has decreased rapidly during the past few decades, whereas the prevalence of subclinical ID has remained substantial.1-3 Subclinical ID is especially common in children aged 1to 3years, in adolescents of both sexes, in women of childbearing age, and in the elderly population.4-8 Because current methods permit the accurate diagnosis of uncomplicated IDA, the focus of clinical interest has shifted to the detection of subclinical ID and to the distinction of ID from other entities in the differential diagnosis of anemia.9 Both serum ferritin and serum transferrin receptor (sTfR) are known to undergo a characteristic sequence of changes, as body iron stores decrease from normal iron-replete levels to those found in IDA (Fig 1).10-13 During the depletion phase (stage I), in which sTfR concentration remains stable, there is a progressive decrease in serum ferritin. 

Phrase: "In developed countries,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282613:Developed Countries [Qualitative Concept]
   861   C0454664:Countries [Geographic Area]

Phrase: "the prevalence of iron deficiency anemia (IDA)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033105:Prevalence [Quantitative Concept]
   753   C0220900:prevalence [Quantitative Concept]

Phrase: "has"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "rapidly during the past few decades,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1444637:Past [Temporal Concept]
   753   C1637379:Rapidly [Qualitative Concept]
   719   C2981279:Decade [Quantitative Concept]

Phrase: "whereas"

Phrase: "the prevalence of subclinical ID"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033105:Prevalence [Quantitative Concept]
   753   C0220900:prevalence [Quantitative Concept]

Phrase: "has"

Phrase: "remained substantial.1-3 Subclinical ID"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   818   C0240066:Iron deficiency [Disease or Syndrome]
   795   C0011155:Deficiency [Functional Concept]
   795   C0162429:Deficiency [Disease or Syndrome]
   795   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   795   C0376520:Iron [Inorganic Chemical]
   795   C1166521:iron [Pharmacologic Substance]
   795   C1623416:deficiency [Qualitative Concept]
   724 E C1636779:% deficient [Quantitative Concept]

Phrase: "is"

Phrase: "especially common in children"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "1to 3years,"

Phrase: "in adolescents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205653:Adolescents [Age Group]

Phrase: "of both sexes,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0009253:Sex [Organism Function]
   966   C0036864:Sex [Behavior]
   966   C0079399:sex [Organism Attribute]
   966   C1314687:Sex [Finding]
   966   C1522384:sex [Organism Attribute]

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "of childbearing age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "and in the elderly population.4-8"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0001792:Elderly [Population Group]
   748   C0032659:Population [Quantitative Concept]
   748   C1257890:Population [Population Group]
   748   C1515981:And [Idea or Concept]
   748   C1999167:elderly [Population Group]

Phrase: "Because"

Phrase: "current methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "permit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "the accurate diagnosis of uncomplicated IDA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   766   C0598285:Accuracy of Diagnosis [Qualitative Concept]
   744   C0011900:Diagnosis [Finding]
   744   C1704338:diagnosis [Qualitative Concept]
   744   C1704656:DIAGNOSIS [Research Activity]

Phrase: "the focus of clinical interest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205234:Focus [Spatial Concept]
   760   C1285542:focus [Functional Concept]

Phrase: "has"

Phrase: "shifted to the detection of subclinical ID"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0240066:Iron deficiency [Disease or Syndrome]
   744   C0011155:Deficiency [Functional Concept]
   744   C0162429:Deficiency [Disease or Syndrome]
   744   C0205211:Subclinical [Qualitative Concept]
   744   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0333051:shifted [Functional Concept]
   744   C0376520:Iron [Inorganic Chemical]
   744   C1166521:iron [Pharmacologic Substance]
   744   C1511790:Detection [Therapeutic or Preventive Procedure]
   744   C1623416:deficiency [Qualitative Concept]
   711 E C2347509:Shift [Phenomenon or Process]

Phrase: "and to the distinction of ID"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0240066:Iron deficiency [Disease or Syndrome]
   748   C0011155:Deficiency [Functional Concept]
   748   C0162429:Deficiency [Disease or Syndrome]
   748   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0376520:Iron [Inorganic Chemical]
   748   C1166521:iron [Pharmacologic Substance]
   748   C1515981:And [Idea or Concept]
   748   C1623416:deficiency [Qualitative Concept]

Phrase: "from other entities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1551338:Entity [Entity]

Phrase: "in the differential diagnosis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011906:Differential Diagnosis [Diagnostic Procedure]
  1000   C0220820:differential diagnosis [Functional Concept]
   861   C0011900:Diagnosis [Finding]
   861   C0443199:Differential [Qualitative Concept]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]
   861   C1705242:Differential [Qualitative Concept]

Phrase: "of anemia.9"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002871:Anaemia [Disease or Syndrome]
   861   C1000483:Anemia [Plant]
   789 E C0857322:anaemic [Finding]

Phrase: "Both serum ferritin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0696113:Serum ferritin [Laboratory Procedure]
   861   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "serum transferrin receptor"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(sTfR"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "undergo"

Phrase: "a characteristic sequence of changes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "as"

Phrase: "body iron stores"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450235:Iron stores [Laboratory Procedure]
   901   C1318241:iron stores [Laboratory or Test Result]
   793   C1698986:Store [Functional Concept]

Phrase: "decrease from normal iron-replete levels"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   790   C0860977:normal iron [Finding]
   783   C0337439:iron levels [Laboratory Procedure]
   783   C0428578:iron levels [Laboratory or Test Result]
   753   C0205307:Normal [Qualitative Concept]
   753   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0376520:Iron [Inorganic Chemical]
   753   C0392756:Decrease [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
   753   C1166521:iron [Pharmacologic Substance]
   753   C2347086:% Normal [Quantitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "to those"

Phrase: "found in IDA"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   862   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   806   C0041782:Deficiency Anemia [Disease or Syndrome]
   806   C0240066:Iron deficiency [Disease or Syndrome]
   760   C0002871:Anaemia [Disease or Syndrome]
   760   C0011155:Deficiency [Functional Concept]
   760   C0150312:Found [Quantitative Concept]
   760   C0162429:Deficiency [Disease or Syndrome]
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1000483:Anemia [Plant]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1623416:deficiency [Qualitative Concept]
   726 E C0243095:Find [Finding]

Phrase: "(Fig 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ").10-13 During the depletion phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205390:Phase [Temporal Concept]
   753   C0333668:Depletion [Functional Concept]

Phrase: "(stage I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441766:Stage I [Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "in which sTfR concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   902   C0683149:serum concentration [Quantitative Concept]
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "remains"

Phrase: "stable, there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205360:Stable [Qualitative Concept]
   861   C1547311:Stable [Intellectual Product]

Phrase: "is"

Phrase: "a progressive decrease in serum ferritin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.10: When the storage deficit is sufficient to restrict the synthesis of hemoglobin and other functional iron compounds, iron-deficient erythropoiesis (IDE) ensues (stage II). 

Phrase: "When"

Phrase: "the storage deficit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0162429:Deficit, NOS [Disease or Syndrome]
   861   C2987487:Deficit [Qualitative Concept]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "restrict"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:restrict [Functional Concept]

Phrase: "the synthesis of hemoglobin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1157477:hemoglobin synthesis [Molecular Function]
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "other functional iron compounds,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206110:Iron Compounds [Inorganic Chemical]
   901   C0684279:Iron Compounds [Chemical Viewed Structurally]
   793   C0205198:Compound [Qualitative Concept]
   793   C1706082:Compound [Chemical]

Phrase: "iron-deficient erythropoiesis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014819:Erythropoiesis [Cell Function,Organ or Tissue Function]
   755 E C0312829:Erythropoietic [Functional Concept]

Phrase: "(IDE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014819:Erythropoiesis [Cell Function,Organ or Tissue Function]
   755 E C0312829:Erythropoietic [Functional Concept]

Phrase: ")"

Phrase: "ensues"

Phrase: "(stage II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441767:Stage II [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.11: The only indicator of early IDE is the compensatorily elevated sTfR concentration.14,15 Finally, IDA (stage III) develops as the hemoglobin (Hb) concentration falls below the lower limit of normal as a result of progressive depletion of the functional iron compartment. 

Phrase: "The only indicator of early IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   744   C1235732:Indicator [Bird]
   744   C1522602:Indicator [Functional Concept]

Phrase: "is"

Phrase: "the compensatorily elevated sTfR concentration.14,"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   845   C0683149:serum concentration [Quantitative Concept]
   818   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C0428545:Serum transferrin [Laboratory Procedure]
   818   C1318186:serum transferrin [Laboratory or Test Result]
   818   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   818   C1619635:Transferrin Receptor [Immunologic Factor]
   795   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0086045:Concentration [Mental Process]
   795   C0205250:Elevated [Qualitative Concept]
   795   C0229671:Serum [Body Substance]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C1442762:TRANSFERRIN [Gene or Genome]
   795   C1446561:Concentration [Quantitative Concept]
   795   C1546774:Serum [Intellectual Product]
   795   C1550100:Serum [Body Substance]
   795   C3163633:Elevated [Qualitative Concept]
   724 E C1880165:Concentrated [Biomedical or Dental Material]
   712 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "15 Finally,"

Phrase: "IDA"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   901   C0041782:Deficiency Anemia [Disease or Syndrome]
   901   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0002871:Anaemia [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1000483:Anemia [Plant]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C0857322:anaemic [Finding]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "(stage III"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441771:Stage III [Intellectual Product]
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "develops as the hemoglobin (Hb) concentration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0019029:haemoglobin concentration [Laboratory or Test Result]
   806   C1314664:Haemoglobin concentration [Laboratory Procedure]
   806   C1318517:Haemoglobin concentration [Laboratory or Test Result]
   797   C0062245:Haemoglobin AS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "falls below the lower limit of normal"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   853   C1518030:Lower Limit of Normal [Quantitative Concept]
   774   C0442816:normal limit [Quantitative Concept]
   774   C1265570:normal limit [Finding]
   748   C0085639:Fall [Finding]
   748   C0205307:Normal [Qualitative Concept]
   748   C0238715:Fall [Temporal Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C0439801:limit [Functional Concept]
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C1549649:Limit [Idea or Concept]
   748   C2003888:Lower [Activity]
   748   C2347086:% Normal [Quantitative Concept]
   748   C2349209:Limit [Conceptual Entity]
   714 E C0205251:low [Qualitative Concept]
   714 E C1299352:Low [Qualitative Concept]
   714 E C1550472:low [Idea or Concept]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of progressive depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]

Phrase: "of the functional iron compartment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.12: View larger version (54K): [in this window] [in a new window]  Fig 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(54K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.13: Phases of advancing ID. 

Phrase: "Phases of advancing ID."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0585064:Phases [Temporal Concept]
   760   C1067936:Phasis [Eukaryote]
   726 E C0205390:Phase [Temporal Concept]
Processing 00000000.tx.14: The gradual diminution of the different iron compartments and the concomitant changes seen in the laboratory analytes are presented schematically in relation to the separate stages of advancing ID. 

Phrase: "The gradual diminution of the different iron compartments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332511:Diminution [Qualitative Concept]

Phrase: "and"

Phrase: "the concomitant changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "seen in the laboratory analytes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C0205397:Seen [Qualitative Concept]
   760   C0443354:Analytes [Chemical Viewed Functionally]
   760   C3244292:laboratory [Functional Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "are"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "schematically in relation to the separate stages of advancing ID."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   756   C0240066:Iron deficiency [Disease or Syndrome]
   738   C0011155:Deficiency [Functional Concept]
   738   C0080103:Relation [Family Group]
   738   C0162429:Deficiency [Disease or Syndrome]
   738   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   738   C0376520:Iron [Inorganic Chemical]
   738   C0443299:Separate [Spatial Concept]
   738   C0869014:relation [Social Behavior]
   738   C1166521:iron [Pharmacologic Substance]
   738   C1306673:Stages [Qualitative Concept]
   738   C1623416:deficiency [Qualitative Concept]
   704 E C0205390:Stage [Temporal Concept]
   704   C0725066:Advance [Medical Device]
   704 E C1300072:Stage [Clinical Attribute]
Processing 00000000.tx.15: Typical laboratory findings are displayed separately for each stage, and the normal values of sTfR, ferritin, and sTfR/log ferritin (TfR-F Index) are presented as 95% reference intervals obtained from our study population of apparently healthy adults after 3months of oral iron supplementation. 

Phrase: "Typical laboratory findings"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C0587081:Laboratory Finding [Finding]
   827   C2607943:findings [Functional Concept]
   827   C2926606:Findings [Clinical Attribute]
   827   C3539655:Findings [Intellectual Product]
   793 E C0037088:Finding [Sign or Symptom]
   793 E C0243095:Finding [Finding]
   793 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "separately for each stage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205390:Stage [Temporal Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]

Phrase: "and"

Phrase: "the normal values of sTfR,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0086715:Normal Values [Quantitative Concept]
   748   C0042295:Values [Qualitative Concept]
   748   C0205307:Normal [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C2347086:% Normal [Quantitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "ferritin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "sTfR/log ferritin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   897   C0696113:Serum ferritin [Laboratory Procedure]
   804   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(TfR-F Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "presented as 95% reference intervals"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   773   C0086715:reference interval [Quantitative Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C1272706:intervals [Temporal Concept]
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]
   726 E C0150312:Present [Quantitative Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]

Phrase: "obtained from our study population of apparently healthy adults"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   764   C2348561:Study Population [Population Group]
   762 E C0681876:Population Study [Research Activity]
   748   C0686750:Healthy adult [Finding]
   742   C0001675:Adults [Age Group]
   742   C0032659:Population [Quantitative Concept]
   742   C0557651:Study [Manufactured Object]
   742   C0750541:apparently [Idea or Concept]
   742   C1257890:Population [Population Group]
   742   C1301820:Obtained [Functional Concept]
   742   C2603343:Study [Research Activity]
   726   C3242284:population health [Health Care Activity]
   709 E C1552227:Adult Health [Intellectual Product]
   709 E C1552259:Adult Health [Professional or Occupational Group]
   708 E C1706450:Adult [Human]
   708 E C1706701:Obtain [Activity]

Phrase: "after 3months"

Phrase: "of oral iron supplementation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242297:Supplementation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.16: Normal Hb concentrations are the reference values currently applied at the Turku University Central Hospital (TUCH). 

Phrase: "Normal Hb concentrations"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0474529:normal haemoglobin [Finding]
   896   C1277200:Normal concentration [Finding]
   884   C0019029:haemoglobin concentration [Laboratory or Test Result]
   884   C1314664:Haemoglobin concentration [Laboratory Procedure]
   884   C1318517:Haemoglobin concentration [Laboratory or Test Result]
   827   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "are"

Phrase: "the reference values currently"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0086715:Reference Values [Quantitative Concept]
   827   C0042295:Values [Qualitative Concept]
   827   C1514811:Reference [Idea or Concept]
   827   C1706462:Reference [Conceptual Entity]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "applied at the Turku University Central Hospital (TUCH)."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   774   C0020028:hospital university [Health Care Related Organization,Manufactured Object]
   748   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   748   C0041740:University [Manufactured Object,Organization]
   748   C0185125:Applied [Health Care Activity]
   748   C0205099:Central [Spatial Concept]
   748   C1510665:Hospital [Qualitative Concept]
   748   C1879652:Central - [Laboratory Procedure]
   714 E C1632850:Apply [Functional Concept]
   714 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.17: The criteria used to define the different stages of ID appear boxed. 

Phrase: "The criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:criteria [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the different stages of ID"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1306673:Stages [Qualitative Concept]
   719 E C0205390:Stage [Temporal Concept]
   719 E C1300072:Stage [Clinical Attribute]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "boxed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179400:Box [Manufactured Object]
   966   C1533124:Box [Medical Device]
Processing 00000000.tx.18: The prevalences of the different subgroups with various degrees of ID in our study population before the supplementation are presented as determined by these criteria. 

Phrase: "The prevalences of the different subgroups"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0033105:Prevalences [Quantitative Concept]
   719 E C0220900:prevalence [Quantitative Concept]

Phrase: "with various degrees"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0449286:degrees [Quantitative Concept]
   861   C0542560:degrees [Intellectual Product]
   827 E C0441889:Degree [Qualitative Concept]
   827 E C1561545:degree [Quantitative Concept]
   827 E C2348088:Degree [Quantitative Concept]

Phrase: "of ID"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0240066:Iron deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "in our study population"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2348561:Study Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C0557651:Study [Manufactured Object]
   861   C1257890:Population [Population Group]
   861   C2603343:Study [Research Activity]

Phrase: "before the supplementation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242297:Supplementation [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "as"

Phrase: "determined by these criteria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.19: Establishing reliable reference values for ferritin and sTfR to study subclinical ID has been challenging because of the strict concepts of conventional reference values and because reference limits have generally been designed to distinguish nonanemic subjects from patients with IDA.16-22 Furthermore, definite exclusion of subclinical ID from reference populations has rarely been achieved by methods other than bone marrow sampling or iron supplementation trials.23,24 To fully exploit the obvious potentials of ferritin and sTfR assays in diagnosis of subclinical ID, their dynamic properties need to be examined over a wide range of iron status. 

Phrase: "Establishing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establishing [Qualitative Concept]

Phrase: "reliable reference values for ferritin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0086715:Reference Values [Quantitative Concept]
   760   C0042295:Values [Qualitative Concept]
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "sTfR to"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0428545:Serum transferrin [Laboratory Procedure]
   861   C1318186:serum transferrin [Laboratory or Test Result]
   861   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   861   C1619635:Transferrin Receptor [Immunologic Factor]
   812   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1442762:TRANSFERRIN [Gene or Genome]
   729 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "subclinical ID"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "challenging because of the strict concepts of conventional reference values"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0086715:Reference Values [Quantitative Concept]
   739   C0042295:Values [Qualitative Concept]
   739   C0178566:concepts [Idea or Concept]
   739   C0439858:Conventional [Qualitative Concept]
   739   C1514811:Reference [Idea or Concept]
   739   C1706462:Reference [Conceptual Entity]
   706   C0798503:Challenge [Clinical Attribute]
   706   C0805586:Challenge [Health Care Activity]
   706 E C1522609:Value [Quantitative Concept]
   706   C3274764:Challenge [Conceptual Entity]

Phrase: "and"

Phrase: "because"

Phrase: "reference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "limits"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0439801:limits [Functional Concept]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]
   916 E C3542948:Limited [Intellectual Product]

Phrase: "have"

Phrase: "generally"

Phrase: "been"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distinguish"

Phrase: "nonanemic subjects from patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with IDA.16-22 Furthermore,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   861   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   827   C0041782:Deficiency Anemia [Disease or Syndrome]
   827   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0450329:16/22 [Quantitative Concept]
   799   C0002871:Anaemia [Disease or Syndrome]
   799   C0011155:Deficiency [Functional Concept]
   799   C0162429:Deficiency [Disease or Syndrome]
   799   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0376520:Iron [Inorganic Chemical]
   799   C1000483:Anemia [Plant]
   799   C1166521:iron [Pharmacologic Substance]
   799   C1623416:deficiency [Qualitative Concept]
   727 E C0857322:anaemic [Finding]
   727 E C1636779:% deficient [Quantitative Concept]

Phrase: "definite exclusion of subclinical ID"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0680251:EXCLUSION [Functional Concept]
   753   C2828389:Exclusion [Activity]

Phrase: "from reference populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "has"

Phrase: "rarely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522498:Rarely [Qualitative Concept]

Phrase: "been"

Phrase: "achieved by methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   756 E C0871511:METHOD [Intellectual Product]

Phrase: "other than bone marrow sampling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005954:Bone marrow sampling [Diagnostic Procedure]
   827   C0441621:Sampling [Diagnostic Procedure]
   827   C0870078:Sampling [Idea or Concept]
   734   C0005953:Bone Marrow [Tissue]

Phrase: "or"

Phrase: "iron supplementation trials.23,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   812   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0376520:Iron [Inorganic Chemical]
   812   C0450348:23 [Quantitative Concept]
   812   C1166521:iron [Pharmacologic Substance]
   779   C0008976:Trial [Research Activity]

Phrase: "24 To fully"

Phrase: "exploit"

Phrase: "the obvious potentials of ferritin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3245505:potentials [Qualitative Concept]

Phrase: "and"

Phrase: "sTfR assays in diagnosis of subclinical ID,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C0005507:Assay [Laboratory Procedure]
   706   C0243073:assay [Qualitative Concept]
   706   C1510438:Assay [Laboratory Procedure]

Phrase: "their dynamic properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "examined over a wide range of iron status."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0332128:Examined [Finding]
   744   C0332464:Wide [Spatial Concept]
   744   C0376520:Iron [Inorganic Chemical]
   744   C0449438:Status [Qualitative Concept]
   744   C1166521:iron [Pharmacologic Substance]
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]
Processing 00000000.tx.20: Additionally, because serum ferritin reflects the storage iron compartment and sTfR reflects the functional iron compartment, these two values can be combined into a ratio, which is reciprocally regulated. 

Phrase: "Additionally,"

Phrase: "because"

Phrase: "serum ferritin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0696113:Serum ferritin [Laboratory Procedure]
   861   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the storage iron compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]

Phrase: "and"

Phrase: "sTfR"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the functional iron compartment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]

Phrase: "these two values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "combined into a ratio,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205195:Combined [Qualitative Concept]
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]
   737 E C0336789:Combine [Manufactured Object]

Phrase: "which"

Phrase: "is"

Phrase: "reciprocally"

Phrase: "regulated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.21: The special value of sTfR/ferritin ratio and the sTfR/log ferritin index (TfR-F Index) in the differential diagnosis of IDA has already been documented.14,16-18,25 Reanalysis of the reference values for ferritin and sTfR would enable this derivative to be used more accurately in definition of the entire range of body iron stores. 

Phrase: "The special value of sTfR/ferritin ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1532109:Ratio value [Quantitative Concept]
   742   C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "the sTfR/log ferritin index"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0918012:Index [Intellectual Product]
   799   C1552854:index [Idea or Concept]
   799   C1637833:% index [Quantitative Concept]
   709   C0696113:Serum ferritin [Laboratory Procedure]

Phrase: "(TfR-F Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: ")"

Phrase: "in the differential diagnosis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011906:Differential Diagnosis [Diagnostic Procedure]
  1000   C0220820:differential diagnosis [Functional Concept]
   861   C0011900:Diagnosis [Finding]
   861   C0443199:Differential [Qualitative Concept]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]
   861   C1705242:Differential [Qualitative Concept]

Phrase: "of IDA"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   901   C0041782:Deficiency Anemia [Disease or Syndrome]
   901   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0002871:Anaemia [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1000483:Anemia [Plant]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C0857322:anaemic [Finding]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "has"

Phrase: "already"

Phrase: "been"

Phrase: "documented.14,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1301725:Documented [Health Care Activity]
   861   C1609436:documented [Idea or Concept]
   827 E C1301746:document [Intellectual Product]
   827 E C1547673:Document [Intellectual Product]

Phrase: "16-18,"

Phrase: "25 Reanalysis of the reference values"

Phrase: "for ferritin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "sTfR"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "would"

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "this derivative to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527240:Derivative [Functional Concept]

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "more accurately in definition of the entire range of body iron stores."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   753   C0450235:Iron stores [Laboratory Procedure]
   753   C1318241:iron stores [Laboratory or Test Result]
   736   C0205172:More [Functional Concept]
   736   C0242821:body [Human]
   736   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   736   C0376520:Iron [Inorganic Chemical]
   736   C0439751:Entire [Quantitative Concept]
   736   C0444667:Entire [Quantitative Concept]
   736   C0460148:Body [Anatomical Structure]
   736   C1166521:iron [Pharmacologic Substance]
   736   C1268086:Body [Anatomical Structure]
   736   C1514721:Range [Quantitative Concept]
   736   C1550452:definition [Idea or Concept]
   736   C1704788:Definition [Conceptual Entity]
   736   C2348147:Range [Quantitative Concept]
   736   C3539107:Definition [Intellectual Product]
   736   C3542016:Range [Intellectual Product]
   703   C1698986:Store [Functional Concept]
Processing 00000000.tx.22: We evaluated the effect of 3months of oral iron supplementation on the iron status of healthy nonanemic subjects as reflected by serum transferrin receptor, serum ferritin, serum transferrin, serum iron, and transferrin saturation levels. 

Phrase: "We"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the effect of 3months of oral iron supplementation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on the iron status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]

Phrase: "of healthy nonanemic subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1708335:HEALTHY SUBJECTS [Population Group]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "as"

Phrase: "reflected by serum transferrin receptor,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C0428545:Serum transferrin [Laboratory Procedure]
   806   C1318186:serum transferrin [Laboratory or Test Result]
   806   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   806   C1619635:Transferrin Receptor [Immunologic Factor]
   760   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0229671:Serum [Body Substance]
   760   C0558058:reflected [Mental Process]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1442762:TRANSFERRIN [Gene or Genome]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]

Phrase: "serum ferritin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0696113:Serum ferritin [Laboratory Procedure]
   861   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "serum transferrin,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0428545:Serum transferrin [Laboratory Procedure]
  1000   C1318186:serum transferrin [Laboratory or Test Result]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "serum iron,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1318312:serum iron [Laboratory Procedure]
   861   C0229671:Serum [Body Substance]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "transferrin saturation levels."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   896   C0202105:Transferrin level [Laboratory Procedure]
   896   C0427432:transferrin level [Laboratory or Test Result]
   848   C1705188:Saturated Level [Quantitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C1277709:Transferrin saturation [Laboratory Procedure]
Processing 00000000.tx.23: Subgroups with iron depletion were identified in this population by using sTfR, ferritin, and the sTfR/log ferritin ratio measurements. 

Phrase: "Subgroups with iron depletion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1079230:subgroups [Virus]
   737 E C1515021:Subgroup [Classification]

Phrase: "were"

Phrase: "identified in this population"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0032659:Population [Quantitative Concept]
   770   C0205396:Identified [Qualitative Concept]
   770   C1257890:Population [Population Group]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "sTfR,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ferritin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "the sTfR/log ferritin ratio measurements."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   889   C0428545:Serum transferrin measurement [Laboratory Procedure]
   884   C0696113:Serum ferritin measurement [Laboratory Procedure]
   860   C0202105:Transferrin measurement [Laboratory Procedure]
   813   C0373607:Ferritin measurement [Laboratory Procedure]
   801   C1261161:Ratio measurement [Laboratory Procedure]
   795   C0242485:measurements [Functional Concept]
Processing 00000000.tx.24: The results of this study define values of sTfR and the sTfR-F Index useful in detecting subclinical ID.  

Phrase: "The results of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "define"

Phrase: "values of sTfR"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "the sTfR-F Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0918012:Index [Intellectual Product]
   804   C1552854:index [Idea or Concept]
   804   C1637833:% index [Quantitative Concept]

Phrase: "useful in detecting subclinical ID."
Processing 00000000.tx.25: MATERIALS AND METHODS Abstract Introduction Methods Results Discussion References Subjects.  

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]
Processing 00000000.tx.26: The protocol of this study was approved by the Joint Committee of Ethics of the Turku University Central Hospital and the University of Turku. 

Phrase: "The protocol of this study"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C1507394:Study Protocol [Intellectual Product]
           Protocol
   797   C2348563:Study Protocol [Intellectual Product]
           Protocol
   760   C0442711:Protocol [Intellectual Product]
   760   C1522729:Protocol [Intellectual Product]

Phrase: "was"

Phrase: "approved by the Joint Committee of Ethics of the Turku University Central Hospital"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   762   C0086021:Hospital Ethics Committee [Professional or Occupational Group]
   749   C0020028:hospital university [Health Care Related Organization,Manufactured Object]
   749   C0085546:Ethics Committee [Professional or Occupational Group]
   749   C1136380:Ethics, Hospital [Idea or Concept]
   735   C0015000:Ethics [Idea or Concept]
   735   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   735   C0022417:Joint [Body Space or Junction]
   735   C0041740:University [Manufactured Object,Organization]
   735   C0205099:Central [Spatial Concept]
   735   C0205540:Approved [Qualitative Concept]
   735   C0392905:Joint, NOS [Body System]
   735   C1269611:Joint [Body Space or Junction]
   735   C1510665:Hospital [Qualitative Concept]
   735   C1527243:ethics [Idea or Concept]
   735   C1706309:Joint [Medical Device]
   735   C1879652:Central - [Laboratory Procedure]
   735   C2699414:Committee [Group]

Phrase: "and"

Phrase: "the University of Turku."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]
Processing 00000000.tx.27: Seventy-five apparently healthy volunteers (25men and 50women; age range, 22to 60years) received 3months of oral iron supplementation with daily administration of 100 mg of elemental iron as ferrous sulfate. 

Phrase: "Seventy-five apparently healthy volunteers"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   840   C1708335:Healthy Volunteers [Population Group]
   804   C0042960:Volunteers [Professional or Occupational Group]
   771 E C1549078:Volunteer [Idea or Concept]
   771 E C1997894:volunteer [Population Group]

Phrase: "(25men"

Phrase: "and"

Phrase: "50women"

Phrase: "; age range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "22to 60years"

Phrase: ")"

Phrase: "received 3months of oral iron supplementation"

Phrase: "with daily administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "of 100 mg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "of elemental iron"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0876023:elemental iron [Inorganic Chemical,Pharmacologic Substance]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "as ferrous sulfate."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0060282:Ferrous sulphate [Inorganic Chemical,Pharmacologic Substance]
   944 E C0720403:Feosol [Pharmacologic Substance]
   944 E C0720405:Fer-in-Sol [Inorganic Chemical,Pharmacologic Substance]
   944 E C0721773:Mol-Iron [Inorganic Chemical,Pharmacologic Substance]
   861   C0038720:Sulfate [Inorganic Chemical]
   861   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   861   C2346592:Ferrous [Element, Ion, or Isotope]
   861   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.28: Of the 75individuals starting the supplementation treatment, 3men and 6women (12.0%) withdrew from the trial prematurely because of adverse gastrointestinal effects. 

Phrase: "Of the 75individuals"

Phrase: "starting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Start [Temporal Concept]

Phrase: "the supplementation treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "3men"

Phrase: "and"

Phrase: "6women"

Phrase: "(12.0%"

Phrase: ")"

Phrase: "withdrew from the trial prematurely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0008976:Trial [Research Activity]
   726   C2349954:Withdraw [Activity]

Phrase: "because of adverse gastrointestinal effects."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C0001688:adverse effects [Functional Concept]
   913   C0879626:Adverse effects [Pathologic Function]
   896 E C0559546:Adverse Effect [Finding]
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.29: One of the female volunteers was found to be anemic (Hb, 113g/L) and was subsequently excluded from the trial. 

Phrase: "One of the female volunteers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "anemic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0857322:anaemic [Finding]

Phrase: "(Hb,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "113g/L)"

Phrase: "and"

Phrase: "was"

Phrase: "subsequently"

Phrase: "excluded from the trial."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0008976:Trial [Research Activity]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.30: The exclusion criteria used were the Hb concentrations used to define anemia in our hospital (128g/L for men and 117g/L for women). 

Phrase: "The exclusion criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680251:Exclusion Criteria [Functional Concept]
   861   C0243161:criteria [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "the Hb concentrations"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0019029:haemoglobin concentration [Laboratory or Test Result]
   983   C1314664:Haemoglobin concentration [Laboratory Procedure]
   983   C1318517:Haemoglobin concentration [Laboratory or Test Result]
   861   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "anemia in our hospital"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0002871:Anaemia [Disease or Syndrome]
   770   C1000483:Anemia [Plant]

Phrase: "(128g/L for men"

Phrase: "and"

Phrase: "117g/L for women"

Phrase: ")."
Processing 00000000.tx.31: Therefore, a total of 65subjects (22men and 43women) succesfully completed the trial. 

Phrase: "Therefore,"

Phrase: "a total of 65subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]

Phrase: "(22men"

Phrase: "and"

Phrase: "43women"

Phrase: ")"

Phrase: "succesfully"

Phrase: "completed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:COMPLETED [Qualitative Concept]

Phrase: "the trial."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008976:Trial [Research Activity]
Processing 00000000.tx.32: Of these 43women, 3were postmenopausal. 

Phrase: "Of these 43women,"

Phrase: "3were"

Phrase: "postmenopausal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232970:postmenopausal [Temporal Concept]
Processing 00000000.tx.33: Study design.  

Phrase: "Study design."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0035171:Study Design [Research Activity]
  1000   C2983265:Study Design [Intellectual Product]
           DESIGN
  1000   C2986888:Study Design [Research Activity]
   861   C0557651:Study [Manufactured Object]
   861   C1707689:Design [Activity]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.34: The iron status of the subjects was assessed at onset of the study (sample A) by assaying a venous blood sample for Hb, hematocrit, mean corpuscular hemoglobin, mean corpuscular volume, erythrocyte count, reticulocyte count, serum ferritin, serum iron, serum transferrin, and serum transferrin receptor (sTfR). 

Phrase: "The iron status of the subjects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449438:Status [Qualitative Concept]

Phrase: "was"

Phrase: "assessed at onset of the study (sample"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0332162:Onset [Qualitative Concept]
   748   C0370003:Sample [Substance]
   748   C0557651:Study [Manufactured Object]
   748   C1516048:Assessed [Activity]
   748   C2347026:Sample [Conceptual Entity]
   748   C2603343:Study [Research Activity]

Phrase: "A) by assaying"

Phrase: "a venous blood sample for Hb,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0444255:Venous blood sample [Body Substance]
   790   C0178913:Blood sample [Body Substance]
   790   C0229667:Venous blood [Tissue]
   790   C1550615:Venous Blood [Body Substance]
   790   C2338243:Venous blood [Tissue]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0042449:Venous [Body Part, Organ, or Organ Component]
   753   C0229664:Blood [Body Substance]
   753   C0348013:Venous [Spatial Concept]
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]

Phrase: "hematocrit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018935:Haematocrit [Laboratory Procedure]
  1000   C0518014:Haematocrit [Laboratory or Test Result]

Phrase: "mean corpuscular hemoglobin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0369183:Mean corpuscular haemoglobin NOS [Laboratory Procedure]
  1000   C1261502:Mean Corpuscular Hemoglobin [Finding]
   827   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0444504:Mean [Quantitative Concept]
   827   C2347634:Mean [Quantitative Concept]
   827   C2348143:Mean [Quantitative Concept]
   755   C1880182:Corpuscle [Body Part, Organ, or Organ Component]

Phrase: "mean corpuscular volume,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0524587:Mean Corpuscular Volume [Laboratory or Test Result]
  1000   C0863148:Mean corpuscular volume - NOS [Laboratory Procedure]
  1000   C1948043:mean corpuscular volume [Laboratory Procedure]
   827   C0444504:Mean [Quantitative Concept]
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2347634:Mean [Quantitative Concept]
   827   C2348143:Mean [Quantitative Concept]
   827   C2700258:Volume [Laboratory Procedure]
   755   C1880182:Corpuscle [Body Part, Organ, or Organ Component]

Phrase: "erythrocyte count,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014772:Erythrocyte Count [Laboratory Procedure]
   861   C0750480:Count [Activity]
   861   C1705566:Count [Quantitative Concept]

Phrase: "reticulocyte count,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206161:Reticulocyte Count [Laboratory Procedure]
  1000   C1318442:reticulocyte count [Laboratory or Test Result]
   861   C0750480:Count [Activity]
   861   C1705566:Count [Quantitative Concept]

Phrase: "serum ferritin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0696113:Serum ferritin [Laboratory Procedure]
   861   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "serum iron,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1318312:serum iron [Laboratory Procedure]
   861   C0229671:Serum [Body Substance]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "serum transferrin,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0428545:Serum transferrin [Laboratory Procedure]
  1000   C1318186:serum transferrin [Laboratory or Test Result]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "serum transferrin receptor"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(sTfR"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.35: The sTfR/log ferritin ratio (TfR-F Index) and transferrin saturation levels were also determined. 

Phrase: "The sTfR/log ferritin ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0456603:Ratio [Quantitative Concept]
   799   C1547037:Ratio [Intellectual Product]
   709   C0696113:Serum ferritin [Laboratory Procedure]

Phrase: "(TfR-F Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "transferrin saturation levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   896   C0202105:Transferrin level [Laboratory Procedure]
   896   C0427432:transferrin level [Laboratory or Test Result]
   848   C1705188:Saturated Level [Quantitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C1277709:Transferrin saturation [Laboratory Procedure]

Phrase: "were"

Phrase: "also"

Phrase: "determined."
Processing 00000000.tx.36: Similar tests were also performed weeks after the discontinuation of supplementation (sample B), a total of 14weeks after its initiation. 

Phrase: "Similar tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "also performed weeks after the discontinuation of supplementation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0439230:weeks [Temporal Concept]
   711 E C0332174:/week [Temporal Concept]

Phrase: "(sample B"

Phrase: ")"

Phrase: ","

Phrase: "a total of 14weeks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]

Phrase: "after its initiation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0589507:Initiation [Mental Process]
  1000   C1158830:Initiation [Genetic Function]
  1000   C1704686:Initiation [Functional Concept]
Processing 00000000.tx.37: None of the subjects had regularly used iron supplements, and none had dietary restrictions. 

Phrase: "None of the subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "had"

Phrase: "regularly used iron supplements,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0721124:iron supplements [Food]
   844 E C2825025:Iron Supplement [Pharmacologic Substance]
   779   C0242295:Supplement [Food]
   779   C1947943:Supplement [Intellectual Product]
   779   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "none"

Phrase: "had"

Phrase: "dietary restrictions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0425422:dietary restrictions [Finding]
   861   C0012155:Dietary [Food]
   861   C2699635:DIETARY [Functional Concept]
   827   C0443288:Restriction [Functional Concept]
Processing 00000000.tx.38: The effect of a possible concomitant infection was excluded in all of the subjects by assessing the white blood cell count, erythrocyte sedimentation rate, and C-reactive protein both before and after supplementation. 

Phrase: "The effect of a possible concomitant infection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "excluded in all of the subjects"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C1554077:Excluded [Idea or Concept]
   753   C2828389:Excluded [Activity]
   719 E C0332196:Exclude [Functional Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "by assessing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516048:Assess [Activity]

Phrase: "the white blood cell count,"
Meta Candidates (Total=28; Excluded=8; Pruned=0; Remaining=20)
  1000   C0023508:Blood Cell Count, White [Laboratory Procedure]
  1000   C0427512:white blood cell count [Laboratory or Test Result]
   923   C0005771:Blood Cell Count [Laboratory Procedure]
   923   C0009555:Blood Cell Count [Laboratory Procedure]
   923   C0023516:White blood cell [Cell]
           White Cell
   861   C0005773:Blood cell [Cell]
   861   C0007584:Cell Count [Laboratory Procedure]
   833 E C2328697:Hemal cell [Cell]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0007457:White [Population Group]
   812   C0007634:Cell [Cell]
   812   C0043157:White [Population Group]
   812   C0220938:White [Qualitative Concept]
   812   C0229664:Blood [Body Substance]
   812   C0750480:Count [Activity]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1705566:Count [Quantitative Concept]
   812   C1948049:Cell [Spatial Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "erythrocyte sedimentation rate,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0086250:Erythrocyte Sedimentation Rate [Laboratory Procedure]
  1000   C1176468:Erythrocyte Sedimentation Rate [Laboratory Procedure]
           Sedimentation rate, NOS
  1000   C1619634:Erythrocyte Sedimentation Rate [Finding]
   901   C0005833:Erythrocyte Sedimentation [Laboratory Procedure]
   827   C0014792:Erythrocyte [Cell]
   827   C0597428:Sedimentation [Laboratory Procedure]
   827   C0871208:Rate [Activity]
   827   C1384604:Sedimentation [Natural Phenomenon or Process]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "C-reactive protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0006560:C-reactive protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1879974:C-Reactive Protein [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205332:Reactive [Qualitative Concept]

Phrase: "both before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "and after supplementation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.39: Diagnostic testing.  

Phrase: "Diagnostic testing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086143:diagnostic testing [Diagnostic Procedure]
   861   C0039593:Testing [Functional Concept]
   861   C0392366:testing [Intellectual Product]
Processing 00000000.tx.40: Blood counts were measured using an automated analyzer (Technicon H*2; Technicon Instruments Corp, Tarrytown, NY). 

Phrase: "Blood counts"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0439157:counts [Quantitative Concept]
   827 E C0750480:Count [Activity]
   827 E C1705566:Count [Quantitative Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an automated analyzer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179038:Analyzer [Medical Device]
   861   C1706246:Analyzer [Manufactured Object]

Phrase: "(Technicon H*2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0011744:h 2 [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "; Technicon Instruments Corp,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: "Tarrytown,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.41: Serum transferrin receptor assays were performed with a commercial kit using a monoclonal antibody in a sandwich immunoezymometric assay (IEMA) format (IDeA; Orion Diagnostica, Turku, Finland). 

Phrase: "Serum transferrin receptor assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed with a commercial kit"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0680536:commercial [Intellectual Product]
   760   C0812225:KIT [Medical Device]
   760   C0884358:Performed [Functional Concept]
   760   C1150635:KIT [Molecular Function]
   760   C1705212:Kit [Medical Device]
   760   C1705213:KIT [Medical Device]
   760   C3272563:Commercial [Intellectual Product]
   760   C3273202:Kit [Manufactured Object]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a monoclonal antibody in a sandwich immunoezymometric assay (IEMA) format"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0746619:monoclonal [Finding]

Phrase: "(IDeA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "; Orion Diagnostica,"

Phrase: "Turku,"

Phrase: "Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.42: The method has been described in detail elsewhere.24 Serum ferritin (the reference range at our hospital: 20to 240g/L for men, 10to 100g/L for women) was measured using an automated time-resolved immunofluorometric assay (Autodelfia, Wallac, Turku, Finland). 

Phrase: "The method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "described in detail elsewhere.24 Serum ferritin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0696113:Serum ferritin [Laboratory Procedure]
   748   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0229671:Serum [Body Substance]
   748   C1522508:Detail [Qualitative Concept]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   748   C1552738:described [Idea or Concept]
   748   C1561567:detail [Functional Concept]

Phrase: "("

Phrase: "the reference range at our hospital"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0086715:Reference Range [Quantitative Concept]
   753   C1514721:Range [Quantitative Concept]
   753   C1514811:Reference [Idea or Concept]
   753   C1706462:Reference [Conceptual Entity]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: ":"

Phrase: "20to 240g/L for men,"

Phrase: "10to 100g/L for women"

Phrase: ")"

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an automated time-resolved immunofluorometric assay"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   937   C0040228:Time-Resolved Immunofluorometric Assay [Laboratory Procedure]
   840   C0016350:Immunofluorometric Assay [Laboratory Procedure]
   804   C0005507:Assay [Laboratory Procedure]
   804   C0040223:Time [Temporal Concept]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]
   804   C1514893:Resolved [Idea or Concept]
   804   C2699488:Resolved [Conceptual Entity]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]

Phrase: "(Autodelfia,"

Phrase: "Wallac,"

Phrase: "Turku,"

Phrase: "Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.43: Serum transferrin (reference range, 1.75to 3.13g/L) was measured using a Behring Nephelometer (Behringwerke AG, Marburg, Germany) together with antibodies obtained from Dakopatts (Dakopatts, Glostrup, Denmark). 

Phrase: "Serum transferrin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0428545:Serum transferrin [Laboratory Procedure]
  1000   C1318186:serum transferrin [Laboratory or Test Result]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(reference range,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0086715:Reference Range [Quantitative Concept]
   861   C1514721:Range [Quantitative Concept]
   861   C1514811:Reference [Idea or Concept]
   861   C1706462:Reference [Conceptual Entity]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "1.75to 3.13g/L)"

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Behring Nephelometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0181994:NEPHELOMETER [Medical Device]

Phrase: "(Behringwerke AG,"

Phrase: "Marburg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "together with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "obtained from Dakopatts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Dakopatts,"

Phrase: "Glostrup,"

Phrase: "Denmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: ")."
Processing 00000000.tx.44: The method was calibrated using the IFCC calibrator (BCR CRM No. 470; Community Bureau of Reference, Commission of the European Communities, Brussels, Belgium). 

Phrase: "The method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "was"

Phrase: "calibrated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the IFCC calibrator"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179515:CALIBRATOR [Manufactured Object]
   861   C1706424:Calibrator [Medical Device]

Phrase: "(BCR CRM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0719068:CRM [Organic Chemical,Pharmacologic Substance]
   861   C1705057:CRM [Clinical Attribute]

Phrase: "No. 470"

Phrase: "; Community Bureau of Reference,"

Phrase: "Commission of the European Communities,"

Phrase: "Brussels,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")."
Processing 00000000.tx.45: Serum iron (reference range, 10to 40mol/L) was measured using an Iron FZ assay (Hoffman-LaRoche, Basel, Switzerland) based on a guanidine hydrochloride/Ferrozine reaction. 

Phrase: "Serum iron"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1318312:serum iron [Laboratory Procedure]
   861   C0229671:Serum [Body Substance]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "(reference range,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0086715:Reference Range [Quantitative Concept]
   861   C1514721:Range [Quantitative Concept]
   861   C1514811:Reference [Idea or Concept]
   861   C1706462:Reference [Conceptual Entity]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "10to 40mol/L)"

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Iron FZ assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "(Hoffman-LaRoche,"

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "based on a guanidine hydrochloride/Ferrozine reaction."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0120447:Guanidine Hydrochloride [Organic Chemical,Pharmacologic Substance]
   748   C0015893:Ferrozine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0018320:guanidine [Organic Chemical]
   748   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.46: Transferrin saturation was calculated as described by Huebers and Finch.26 Statistical analyses.  

Phrase: "Transferrin saturation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1277709:Transferrin saturation [Laboratory Procedure]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0522534:Saturation [Phenomenon or Process]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   789 E C1705188:SATURATED [Quantitative Concept]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "as"

Phrase: "described by Huebers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Finch.26 Statistical analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0871424:statistical analysis [Research Activity]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]
Processing 00000000.tx.47: The 95% reference intervals for the various parameters as well as the 90% confidence intervals for the respective reference limits were calculated using the GraphROC for Windows software package (Veli Kairisto, Department of Clinical Chemistry, Turku University Central Hospital, Turku, Finland).27 The distribution scattergram was visualized using Fig P Software (Fig P Software, Durham, NC). 

Phrase: "The 95% reference intervals for the various parameters"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   744   C1272706:intervals [Temporal Concept]
   744   C1514811:Reference [Idea or Concept]
   744   C1706462:Reference [Conceptual Entity]
   737   C0086715:reference interval [Quantitative Concept]
   711 E C1552654:Interval [Idea or Concept]
   711 E C1552713:Interval [Intellectual Product]

Phrase: "as well as"

Phrase: "the 90% confidence intervals for the respective reference limits"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   764   C0009667:Confidence Intervals [Quantitative Concept]
   762   C0237530:Confidence Limits [Quantitative Concept]
   745   C0086715:reference interval [Quantitative Concept]
   742   C0237529:Confidence [Mental Process]
   742   C1272706:intervals [Temporal Concept]
   742   C1704725:Confidence [Qualitative Concept]
   742   C1704726:Confidence [Mental Process]
   708 E C1552654:Interval [Idea or Concept]
   708 E C1552713:Interval [Intellectual Product]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the GraphROC for Windows software package"

Phrase: "(Veli Kairisto,"

Phrase: "Department of Clinical Chemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Turku University Central Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   875   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "Turku,"

Phrase: "Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: ").27"

Phrase: "The distribution scattergram"

Phrase: "was"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Fig P Software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Fig P Software,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "Durham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454851:Durham [Geographic Area]

Phrase: "NC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027964:NC [Geographic Area]
  1000   C0028407:NC [Geographic Area]
  1000   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.48: All P values were calculated by Student's t-test using the Microsoft Windows for Workgroups software package (Microsoft Corp, Redmond, WA).  

Phrase: "All P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "calculated by Student's t-test"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Microsoft Windows for Workgroups software package"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0557702:windows [Manufactured Object]
   714 E C1272706:Window [Temporal Concept]
   714 E C1704674:Window [Manufactured Object]

Phrase: "(Microsoft Corp,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "Redmond,"

Phrase: "WA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:WA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.49: RESULTS Abstract Introduction Methods Results Discussion References In the group of women, 3months of supplementation with ferrous sulfate produced a highly significant change in sTfR, ferritin, and TfR-F Index. 

Phrase: "RESULTS Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "References In the group of women,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C0242543:Women's Group [Population Group]
   783   C0680399:reference group [Population Group]
   753   C0043210:Women [Population Group]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1514811:Reference [Idea or Concept]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1706462:Reference [Conceptual Entity]

Phrase: "3months of supplementation"

Phrase: "with ferrous sulfate"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0060282:Ferrous sulphate [Inorganic Chemical,Pharmacologic Substance]
   944 E C0720403:Feosol [Pharmacologic Substance]
   944 E C0720405:Fer-in-Sol [Inorganic Chemical,Pharmacologic Substance]
   944 E C0721773:Mol-Iron [Inorganic Chemical,Pharmacologic Substance]
   861   C0038720:Sulfate [Inorganic Chemical]
   861   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   861   C2346592:Ferrous [Element, Ion, or Isotope]
   861   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "produced"

Phrase: "a highly significant change in sTfR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "ferritin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "TfR-F Index."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]
Processing 00000000.tx.50: There was only a modest, but statistically significant, change in serum iron (data not shown) and transferrin saturation (Table 1). 

Phrase: "There"

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a modest,"

Phrase: "but"

Phrase: "statistically significant, change in serum iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "transferrin saturation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1277709:Transferrin saturation [Laboratory Procedure]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0522534:Saturation [Phenomenon or Process]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   789 E C1705188:SATURATED [Quantitative Concept]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.51: In the group of men, the parameters reflecting iron status were not significantly altered. 

Phrase: "In the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "of men,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "the parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "iron status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]

Phrase: "were"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "altered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]
Processing 00000000.tx.52: Changes in the sTfR and the TfR-F Index mainly occurred in subjects in which these values were elevated in the samples taken before supplementation. 

Phrase: "Changes in the sTfR"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "the TfR-F Index mainly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0918012:Index [Intellectual Product]
   812   C1552854:index [Idea or Concept]
   812   C1637833:% index [Quantitative Concept]

Phrase: "occurred in subjects"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1709305:Occurred [Activity]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "in which"

Phrase: "these values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "elevated in the samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205250:Elevated [Qualitative Concept]
   770   C3163633:Elevated [Qualitative Concept]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "taken before supplementation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.53: Changes in ferritin were more variable, also occurring in subjects considered to be iron-replete on the basis of presupplementation testing. 

Phrase: "Changes in ferritin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "more variable, also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205172:More [Functional Concept]
   827   C0439828:Variable [Qualitative Concept]

Phrase: "occurring in subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C1709305:Occur [Activity]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]
   756   C2745955:OCCUR [Temporal Concept]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "iron-replete on the basis of presupplementation testing."
Processing 00000000.tx.54: The distribution of the TfR-F Index was narrowed most markedly. 

Phrase: "The distribution of the TfR-F Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1707993:F-Distribution [Quantitative Concept]
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "narrowed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333164:Narrowed [Quantitative Concept]
   966 E C0205168:Narrow [Qualitative Concept]
   966 E C0332463:Narrow [Spatial Concept]

Phrase: "most markedly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0522501:Markedly [Qualitative Concept]
Processing 00000000.tx.55: Differences between male and female subjects before supplementation were seen in sTfR (P<.0003), ferritin (P<.0005), and the TfR-F Index (P<.00001). 

Phrase: "Differences between male"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015780:Female [Finding]
  1000   C0043210:female [Population Group]
  1000   C0086287:female [Population Group]
  1000   C1705497:Female [Qualitative Concept]
  1000   C1705498:Female [Qualitative Concept]

Phrase: "subjects before supplementation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   790   C0681850:Subject [Group]
   790   C1550501:{Subject} [Idea or Concept]
   790   C1706203:Subject [Idea or Concept]
   790   C2349001:Subject [Human]
   790   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "seen in sTfR"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   806   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C0428545:Serum transferrin [Laboratory Procedure]
   806   C1318186:serum transferrin [Laboratory or Test Result]
   806   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   806   C1619635:Transferrin Receptor [Immunologic Factor]
   760   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205397:Seen [Qualitative Concept]
   760   C0229671:Serum [Body Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1442762:TRANSFERRIN [Gene or Genome]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "(P<.0003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "ferritin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(P<.0005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the TfR-F Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "(P<.00001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.56: After supplementation, the difference in sTfR values between men and women was eliminated (P<.4). 

Phrase: "After supplementation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242297:Supplementation [Therapeutic or Preventive Procedure]

Phrase: "the difference in sTfR values"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "between men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "and"

Phrase: "women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "was"

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "(P<.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.57: However, differences remained in ferritin values (P<.001) and consequently in the TfR-F Index (P<.02). 

Phrase: "However,"

Phrase: "differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "remained in ferritin values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "(P<.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "consequently in the TfR-F Index"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   753   C0439133:(f) [Intellectual Product]
   753   C0918012:Index [Intellectual Product]
   753   C1552854:index [Idea or Concept]
   753   C1553038:[f] [Quantitative Concept]
   753   C1637833:% index [Quantitative Concept]

Phrase: "(P<.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.58: The significant difference between men and women in Hb, hematocrit, and erythrocyte count (P<.00001) remained unaffected by supplementation. 

Phrase: "The significant difference between men"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "women in Hb,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0043210:Women [Population Group]

Phrase: "hematocrit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018935:Haematocrit [Laboratory Procedure]
  1000   C0518014:Haematocrit [Laboratory or Test Result]

Phrase: "and"

Phrase: "erythrocyte count"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014772:Erythrocyte Count [Laboratory Procedure]
   861   C0750480:Count [Activity]
   861   C1705566:Count [Quantitative Concept]

Phrase: "(P<.00001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "remained"

Phrase: "unaffected by supplementation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.59: No supplementation-induced changes or significant differences between men and women were observed in values of transferrin, iron, and transferrin saturation.  

Phrase: "No supplementation-induced changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "significant differences between men"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "were"

Phrase: "observed in values of transferrin,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0042295:Values [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1442762:TRANSFERRIN [Gene or Genome]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "iron,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "and"

Phrase: "transferrin saturation."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1277709:Transferrin saturation [Laboratory Procedure]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0522534:Saturation [Phenomenon or Process]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   789 E C1705188:SATURATED [Quantitative Concept]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.60: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.61: Results Within Four Parameters of Iron Status Showing Significant Differences Between Samples Obtained Before and After a 3-Month Oral Iron Supplementation The prevalence of the nonanemic stages of ID in our population was studied retrospectively by comparing the individual values of the separate parameters in the presupplementation samples (sample A) with the respective 95% reference intervals calculated from results obtained after supplementation (sample B) (Table 2 and Fig 1). 

Phrase: "Results Within Four Parameters of Iron Status"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1550399:Result Status [Classification]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "Showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "Significant Differences Between Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "Obtained Before"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   833   C1301820:Obtained [Functional Concept]
   799 E C1706701:Obtain [Activity]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0205217:Increased [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442805:Increase [Functional Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "and After a 3-Month Oral Iron Supplementation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C2346593:Iron 3+ [Element, Ion, or Isotope]
   744   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   744   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0376520:Iron [Inorganic Chemical]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0442027:Oral [Spatial Concept]
   744   C1166521:iron [Pharmacologic Substance]
   744   C1515981:And [Idea or Concept]

Phrase: "The prevalence of the nonanemic stages of ID"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0033105:Prevalence [Quantitative Concept]
   742   C0220900:prevalence [Quantitative Concept]

Phrase: "in our population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "was"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "retrospectively by comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707455:Compare [Activity]

Phrase: "the individual values of the separate parameters"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0042295:Values [Qualitative Concept]
   741   C0549193:Parameter Value [Spatial Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "in the presupplementation samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "A) with the respective 95% reference intervals"

Phrase: "calculated from results"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "obtained after supplementation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(sample B) (Table 2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0039224:Table [Manufactured Object]
   812   C0370003:Sample [Substance]
   812   C1706073:Table [Medical Device]
   812   C1706074:Table [Intellectual Product]
   812   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "Fig 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.62: The decision limit of ferritin was set at 22g/L, as this concentration represented the lower limit of the 95% reference interval in the group of supplemented men (90% confidence interval, 22to 38g/L). 

Phrase: "The decision limit of ferritin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439801:limit [Functional Concept]
   760   C1549649:Limit [Idea or Concept]
   760   C2349209:Limit [Conceptual Entity]

Phrase: "was"

Phrase: "set at 22g/L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "as"

Phrase: "this concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "the lower limit of the 95% reference interval"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   744   C0439801:limit [Functional Concept]
   744   C0441994:Lower [Spatial Concept]
   744   C1548802:Lower [Body Location or Region]
   744   C1549649:Limit [Idea or Concept]
   744   C2003888:Lower [Activity]
   744   C2349209:Limit [Conceptual Entity]
   711 E C0205251:low [Qualitative Concept]
   711 E C1299352:Low [Qualitative Concept]
   711 E C1550472:low [Idea or Concept]

Phrase: "in the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "of supplemented men (90% confidence interval,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   840   C0009667:Confidence Interval [Quantitative Concept]
   804   C0237529:Confidence [Mental Process]
   804   C1272706:Interval [Temporal Concept]
   804   C1552654:Interval [Idea or Concept]
   804   C1552713:Interval [Intellectual Product]
   804   C1704725:Confidence [Qualitative Concept]
   804   C1704726:Confidence [Mental Process]
   733 E C0558095:Confident [Individual Behavior]
   704 E C0009669:confidentiality [Idea or Concept]

Phrase: "22to 38g/L)."
Processing 00000000.tx.63: Furthermore, the range, which contained all subjects with elevated sTfR (>2.75 mg/L) before supplementation was 4to 21g/L (Fig 2). 

Phrase: "Furthermore,"

Phrase: "the range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "which"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "all subjects with elevated sTfR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "("

Phrase: ">2.75 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "L)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "before"

Phrase: "supplementation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242297:Supplementation [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "4to 21g/L (Fig 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0349966:Fig [Food]
   804   C1337208:FIG [Food]
   804   C1959943:21G [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.64: Of the 65subjects who completed the trial, 25 were retrospectively judged to have had storage iron depletion (stage I) or depletion of the functional compartment (IDE, stage II) (Fig 1). 

Phrase: "Of the 65subjects"

Phrase: "who"

Phrase: "completed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:COMPLETED [Qualitative Concept]

Phrase: "the trial,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008976:Trial [Research Activity]

Phrase: "25"

Phrase: "were"

Phrase: "retrospectively"

Phrase: "judged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0221191:Judge [Professional or Occupational Group]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "had"

Phrase: "storage iron depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333668:Depletion [Functional Concept]

Phrase: "(stage I)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441766:Stage I [Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "depletion of the functional compartment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333668:Depletion [Functional Concept]

Phrase: "(IDE,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014819:Erythropoiesis [Cell Function,Organ or Tissue Function]
   755 E C0312829:Erythropoietic [Functional Concept]

Phrase: "stage II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441767:Stage II [Intellectual Product]

Phrase: ")"

Phrase: "(Fig 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.65: Supplementation-induced changes in these 25subjects were highly significant as judged by sTfR, ferritin, and TfR-F Index (Table 1). 

Phrase: "Supplementation-induced changes in these 25subjects"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "highly significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1299395:Highly significant [Qualitative Concept]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "as"

Phrase: "judged by sTfR,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C0428545:Serum transferrin [Laboratory Procedure]
   806   C1318186:serum transferrin [Laboratory or Test Result]
   806   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   806   C1619635:Transferrin Receptor [Immunologic Factor]
   760   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0229671:Serum [Body Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1442762:TRANSFERRIN [Gene or Genome]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726   C0221191:Judge [Professional or Occupational Group]

Phrase: "ferritin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "TfR-F Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.66: Changes observed in other parameters indicative of iron status, including transferrin saturation, were absent or variable (data not shown).  

Phrase: "Changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "observed in other parameters"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0449381:Parameters [Finding]
   770   C1441672:Observed [Functional Concept]
   737 E C0549193:Parameter [Spatial Concept]
   737 E C1704769:Parameter [Conceptual Entity]
   737 E C2350001:Parameter [Quantitative Concept]

Phrase: "indicative of iron status,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "transferrin saturation,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1277709:Transferrin saturation [Laboratory Procedure]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0522534:Saturation [Phenomenon or Process]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   789 E C1705188:SATURATED [Quantitative Concept]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "absent"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332197:Absent [Quantitative Concept]
  1000   C2699517:ABSENT [Finding]
   928 E C0424530:Absences [Finding]
   928 E C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "variable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:Variable [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.67: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.68: The Median 95% Reference Intervals Currently in Use and as Suggested by the Results of This Study View larger version (16K): [in this window] [in a new window]  Fig 2. 

Phrase: "The Median 95% Reference Intervals"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0086715:reference interval [Quantitative Concept]
   812   C1272706:intervals [Temporal Concept]
   812   C1514811:Reference [Idea or Concept]
   812   C1706462:Reference [Conceptual Entity]
   779 E C1552654:Interval [Idea or Concept]
   779 E C1552713:Interval [Intellectual Product]

Phrase: "Currently in Use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0042153:use [Functional Concept]
   827   C0457083:Use [Functional Concept]
   827   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "as"

Phrase: "Suggested by the Results of This Study"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0683954:results study [Finding]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C1705535:Suggest [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.69: Distribution of ferritin in subjects with normal sTfR and those with elevated sTfR. 

Phrase: "Distribution of ferritin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520511:distribution [Idea or Concept]
   790   C1704711:Distribution [Functional Concept]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with normal sTfR"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0428545:Serum transferrin [Laboratory Procedure]
   861   C1318186:serum transferrin [Laboratory or Test Result]
   861   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   861   C1619635:Transferrin Receptor [Immunologic Factor]
   812   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1442762:TRANSFERRIN [Gene or Genome]
   729 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "those with elevated sTfR."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0428545:Serum transferrin [Laboratory Procedure]
   790   C1318186:serum transferrin [Laboratory or Test Result]
   790   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   790   C1619635:Transferrin Receptor [Immunologic Factor]
   753   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205250:Elevated [Qualitative Concept]
   753   C0229671:Serum [Body Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1442762:TRANSFERRIN [Gene or Genome]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C3163633:Elevated [Qualitative Concept]
Processing 00000000.tx.70: The ferritin concentrations of iron-replete and iron-deplete (diminished or exhausted iron stores) subjects (sTfR <2.75 mg/L) are compared with the corresponding values of subjects with IDE, ie, depletion of the functional iron compartment (sTfR >2.75 mg/L). 

Phrase: "The ferritin concentrations of iron-replete"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "iron-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "deplete"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   944   C1550032:Unload [Idea or Concept]
   944   C1880497:Empty [Qualitative Concept]
   944   C1996907:Emptying [Activity]
   916 E C0333668:Depleted [Functional Concept]

Phrase: "("

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "or"

Phrase: "exhausted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0392674:Exhausted [Sign or Symptom]
   966 E C0178629:exhaust [Hazardous or Poisonous Substance]

Phrase: "iron stores"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450235:Iron stores [Laboratory Procedure]
  1000   C1318241:iron stores [Laboratory or Test Result]
   827   C1698986:Store [Functional Concept]

Phrase: ")"

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "(sTfR"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "<2.75 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "L)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "are"

Phrase: "compared with the corresponding values of subjects"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0042295:Values [Qualitative Concept]
   748   C1707455:Compared [Activity]
   714   C0681850:Subject [Group]
   714 E C1522609:Value [Quantitative Concept]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "with IDE,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014819:Erythropoiesis [Cell Function,Organ or Tissue Function]
   755 E C0312829:Erythropoietic [Functional Concept]

Phrase: "ie"

Phrase: ","

Phrase: "depletion of the functional iron compartment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0333668:Depletion [Functional Concept]

Phrase: "(sTfR"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ">2.75 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "L)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.71: The solid, horizontal line represents the ferritin concentration of 22g/L, which we suggest to be used as a cutoff value for clinically relevant depletion of the storage iron compartment.  

Phrase: "The solid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205208:Solid [Qualitative Concept]
  1000   C0302909:Solid [Substance]
  1000   C1378566:Solid [Biomedical or Dental Material]

Phrase: "horizontal line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the ferritin concentration of 22g/L,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "which"

Phrase: "we"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "used as a cutoff value"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C1273517:used [Finding]
   760   C1442160:Cutoff [Functional Concept]
   760   C1522609:Value [Quantitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "for clinically relevant depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333668:Depletion [Functional Concept]

Phrase: "of the storage iron compartment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.72: DISCUSSION Abstract Introduction Methods Results Discussion References The transition from the normal iron-replete state to the development of IDA entails two sequential processes (Fig 1): depletion of the storage iron compartment (stage I), followed by its exhaustion and the consequent initiation of depletion of the functional iron compartment in the setting of continued iron loss (stage II). 

Phrase: "DISCUSSION Abstract Introduction Methods Results Discussion"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The transition from the normal iron-replete state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1554158:State transition [Idea or Concept]
   744   C0599156:Transition [Cell or Molecular Dysfunction]
   744   C2700061:Transition [Activity]

Phrase: "to the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of IDA entails two sequential processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1184743:Process [Body Part, Organ, or Organ Component]
   762   C1522240:Process [Phenomenon or Process]

Phrase: "(Fig 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ":"

Phrase: "depletion of the storage iron compartment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0333668:Depletion [Functional Concept]

Phrase: "(stage I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441766:Stage I [Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "followed by its exhaustion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0392674:Exhaustion [Sign or Symptom]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "the consequent initiation of depletion of the functional iron compartment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0589507:Initiation [Mental Process]
   739   C1158830:Initiation [Genetic Function]
   739   C1704686:Initiation [Functional Concept]

Phrase: "in the setting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0542559:setting [Functional Concept]
  1000   C1318139:{Setting} [Quantitative Concept]

Phrase: "of continued iron loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517945:Loss [Quantitative Concept]

Phrase: "(stage II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441767:Stage II [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.73: There are no additional physiologic phenomena associated with the development of IDA (stage III), which is merely a sequel of progressive depletion of the functional compartment. 

Phrase: "There"

Phrase: "are"

Phrase: "no additional physiologic phenomena"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   851   C2350828:Physiological Phenomena [Physiologic Function]
   827   C1882365:Phenomena [Phenomenon or Process]

Phrase: "associated with the development of IDA"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   848   C1843575:Associated with iron deficiency anemia [Finding]
   800   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   770   C0041782:Deficiency Anemia [Disease or Syndrome]
   770   C0240066:Iron deficiency [Disease or Syndrome]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0002871:Anaemia [Disease or Syndrome]
   744   C0011155:Deficiency [Functional Concept]
   744   C0162429:Deficiency [Disease or Syndrome]
   744   C0243107:development [Physiologic Function]
   744   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0376520:Iron [Inorganic Chemical]
   744   C0678723:Development [Organism Function]
   744   C1000483:Anemia [Plant]
   744   C1166521:iron [Pharmacologic Substance]
   744   C1527148:Development [Functional Concept]
   744   C1623416:deficiency [Qualitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(stage III"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441771:Stage III [Intellectual Product]
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "merely"

Phrase: "a sequel of progressive depletion of the functional compartment."
Processing 00000000.tx.74: Though the mechanisms linking the changes in iron status to the consequent changes observed in the various measurements have been well-documented,11-15,25,28-30 accurate assessment of the iron status in an individual patient requires that the normal values established for various parameters be reexamined. 

Phrase: "Though"

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "the changes in iron status"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025320:The change [Physiologic Function]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "to the consequent changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "observed in the various measurements"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242485:measurements [Functional Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1441672:Observed [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "well-documented,11-15,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0205170:Well [Qualitative Concept]
   812   C1301725:Documented [Health Care Activity]
   812   C1609436:documented [Idea or Concept]
   812   C3146287:Well [Manufactured Object]
   779 E C1301746:document [Intellectual Product]
   779 E C1547673:Document [Intellectual Product]

Phrase: "25,"

Phrase: "28-30 accurate assessment of the iron status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1261322:Assessment [Health Care Activity]
   744   C1516048:Assessment [Activity]

Phrase: "in an individual patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "requires"

Phrase: "that"

Phrase: "the normal values"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0086715:Normal Values [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "established for various parameters"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C0443211:Established [Qualitative Concept]
   770   C0449381:Parameters [Finding]
   770   C1272684:Established [Qualitative Concept]
   737 E C0549193:Parameter [Spatial Concept]
   737 E C1704769:Parameter [Conceptual Entity]
   737 E C2350001:Parameter [Quantitative Concept]

Phrase: "be"

Phrase: "reexamined."
Processing 00000000.tx.75: In this study, a population sample of apparently healthy, nonanemic adults was subjected to 3months of oral iron supplementation to produce an iron-replete population. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "a population sample of apparently healthy, nonanemic adults"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0370003:Sample [Substance]
   744   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "subjected to 3months of oral iron supplementation to"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   744   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0376520:Iron [Inorganic Chemical]
   744   C0442027:Oral [Spatial Concept]
   744   C1166521:iron [Pharmacologic Substance]
   711   C0681850:Subject [Group]
   711   C1550501:{Subject} [Idea or Concept]
   711   C1706203:Subject [Idea or Concept]
   711   C2349001:Subject [Human]
   711   C2697811:Subject [Functional Concept]

Phrase: "produce"

Phrase: "an iron-replete population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.76: The samples obtained before supplementation (A) had values similar to those used to establish reference values for the various indices of iron status.31-34 Samples drawn after supplementation (B) were considered to represent the values of an iron-replete population. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "obtained before supplementation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(A)"

Phrase: "had"

Phrase: "values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "similar to those used to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "reference values for the various indices of iron status.31-34 Samples"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0086715:Reference Values [Quantitative Concept]
   736   C0042295:Values [Qualitative Concept]
   736   C1514811:Reference [Idea or Concept]
   736   C1706462:Reference [Conceptual Entity]
   718   C1881192:Index Value [Quantitative Concept]
   703 E C1522609:Value [Quantitative Concept]

Phrase: "drawn after supplementation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   756   C0013113:Draw [Intellectual Product]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the values of an iron-replete population."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.77: The prevalence of the nonanemic stages of ID were studied retrospectively by comparing the individual values of the separate parameters in the presupplementation samples with the corresponding 95% reference intervals from the postsupplementation samples. 

Phrase: "The prevalence of the nonanemic stages of ID"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0033105:Prevalence [Quantitative Concept]
   742   C0220900:prevalence [Quantitative Concept]

Phrase: "were"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "retrospectively by comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707455:Compare [Activity]

Phrase: "the individual values of the separate parameters"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0042295:Values [Qualitative Concept]
   741   C0549193:Parameter Value [Spatial Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "in the presupplementation samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "with the corresponding 95% reference intervals"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0086715:reference interval [Quantitative Concept]
   812   C1272706:intervals [Temporal Concept]
   812   C1514811:Reference [Idea or Concept]
   812   C1706462:Reference [Conceptual Entity]
   779 E C1552654:Interval [Idea or Concept]
   779 E C1552713:Interval [Intellectual Product]

Phrase: "from the postsupplementation samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.78: The effects of iron supplementation on the various laboratory values reflecting iron status were expected to be in agreement with findings from earlier studies and reviews.13,35,36 Ferritin measurements have been used to differentiate between normality and IDA, and the reference limits have been designed accordingly. 

Phrase: "The effects of iron supplementation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the various laboratory values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "iron status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]

Phrase: "were"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C2987476:Be [Conceptual Entity]

Phrase: "with findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "from earlier studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "reviews.13,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0282443:reviews [Intellectual Product]
   827 E C1552617:Review [Idea or Concept]

Phrase: "35,"

Phrase: "36 Ferritin measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0373607:Ferritin measurement [Laboratory Procedure]
   827   C0242485:measurements [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "differentiate between normality"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0205615:differentiate [Qualitative Concept]
   790   C0949333:Normality [Qualitative Concept]
   790   C1882114:Normality [Quantitative Concept]
   718 E C0205307:Normal [Qualitative Concept]
   718 E C0439166:% normal [Quantitative Concept]
   718 E C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "IDA,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   901   C0041782:Deficiency Anemia [Disease or Syndrome]
   901   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0002871:Anaemia [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1000483:Anemia [Plant]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C0857322:anaemic [Finding]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "and"

Phrase: "the reference limits"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0439801:limits [Functional Concept]
   827 E C1549649:Limit [Idea or Concept]
   827 E C2349209:Limit [Conceptual Entity]
   777 E C3542948:Limited [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "accordingly."
Processing 00000000.tx.79: However, disagreement still remains on the value, which indicates clinically relevant storage iron depletion. 

Phrase: "However,"

Phrase: "disagreement still"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680238:Disagreement [Social Behavior]

Phrase: "remains on the value,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1522609:Value [Quantitative Concept]

Phrase: "which"

Phrase: "indicates"

Phrase: "clinically relevant storage iron depletion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0333668:Depletion [Functional Concept]
Processing 00000000.tx.80: This is mainly due to the fairly large physiologic variability occurring between individual patients.5,28 The fact that ferritin is a known acute-phase reactant also complicates its use as a marker of ID in acute or chronic inflammatory diseases.28,37-44 To define the cut-off value for ferritin indicative of storage iron depletion, comparison was made of the the presupplementation ferritin and TfR levels observed in normals and storage iron-deficient patients with those observed in patients having IDE (Fig 2). 

Phrase: "This"

Phrase: "is"

Phrase: "mainly due to the fairly large physiologic variability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0205463:Physiologic [Functional Concept]
   744   C0549177:Large [Quantitative Concept]
   744   C2827666:Variability [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]

Phrase: "occurring between individual patients.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0027361:Individual [Population Group]
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0237401:Individual [Human]
   726   C1709305:Occur [Activity]
   726   C2745955:OCCUR [Temporal Concept]

Phrase: "28"

Phrase: "The fact"

Phrase: "that ferritin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "a known acute-phase reactant also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0001347:Acute phase reactant [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0439557:Acute phase [Temporal Concept]
   804   C0205178:acute [Temporal Concept]
   804   C0205390:Phase [Temporal Concept]

Phrase: "complicates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231242:complicate [Functional Concept]

Phrase: "its use as a marker of ID"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1524063:Use of [Functional Concept]
   744   C0042153:use [Functional Concept]
   744   C0457083:Use [Functional Concept]
   744   C1947944:Use [Intellectual Product]

Phrase: "in acute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205178:acute [Temporal Concept]

Phrase: "or"

Phrase: "chronic inflammatory diseases.28,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   912   C1290886:Chronic inflammatory disease [Disease or Syndrome]
   875   C0008679:Chronic diseases [Disease or Syndrome]
   844   C1290884:Inflammatory disease [Disease or Syndrome]
   812   C0012634:Diseases [Disease or Syndrome]
   812   C0205191:chronic [Temporal Concept]
   812   C0333348:Inflammatory [Functional Concept]
   741 E C1836721:MALS [Finding]
   741 E C3538764:MALS [Gene or Genome]
   741 E C3540595:MAL [Gene or Genome]

Phrase: "37-44 To"

Phrase: "define"

Phrase: "the cut-off value for ferritin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1442160:Cutoff [Functional Concept]
   753   C0000925:Cut [Injury or Poisoning]
   753   C1522609:Value [Quantitative Concept]
   753   C1883724:CUT [Phenomenon or Process]

Phrase: "indicative of storage iron depletion,"

Phrase: "comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "was"

Phrase: "made of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1881534:Make [Functional Concept]

Phrase: "the presupplementation ferritin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "TfR levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "observed in normals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1441672:Observed [Functional Concept]
   756   C0205307:Normal [Qualitative Concept]
   756   C0439166:% normal [Quantitative Concept]
   756   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "storage iron-deficient patients with those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "observed in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1441672:Observed [Functional Concept]

Phrase: "having"

Phrase: "IDE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014819:Erythropoiesis [Cell Function,Organ or Tissue Function]
   755 E C0312829:Erythropoietic [Functional Concept]

Phrase: "(Fig 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.81: The range of ferritin values in the 17female subjects with IDE was found to be 4to 21g/L, which suggests that concentrations <22 g/L could be used to define clinically relevant storage depletion. 

Phrase: "The range of ferritin values"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1547411:Value range [Idea or Concept]
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "in the 17female"

Phrase: "subjects with IDE"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0011155:Deficient [Functional Concept]
   760   C0014819:Erythropoiesis [Cell Function,Organ or Tissue Function]
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C0681850:Subject [Group]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1636779:% deficient [Quantitative Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "4to 21g/L,"

Phrase: "which"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "<22 g/L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0439294:g l [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "clinically relevant storage depletion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0333668:Depletion [Functional Concept]
Processing 00000000.tx.82: The lower limit of the 95% reference interval in our sample of supplemented men was also 22g/L. 

Phrase: "The lower limit of the 95% reference interval"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   744   C0439801:limit [Functional Concept]
   744   C0441994:Lower [Spatial Concept]
   744   C1548802:Lower [Body Location or Region]
   744   C1549649:Limit [Idea or Concept]
   744   C2003888:Lower [Activity]
   744   C2349209:Limit [Conceptual Entity]
   711 E C0205251:low [Qualitative Concept]
   711 E C1299352:Low [Qualitative Concept]
   711 E C1550472:low [Idea or Concept]

Phrase: "in our sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "of supplemented men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0025266:Men [Population Group]
   827 E C0024554:MAN [Finding]
   827 E C0086418:Man [Human]

Phrase: "was"

Phrase: "also 22g/L."
Processing 00000000.tx.83: Thus, this concentration can be used as a cut-off value for both men and women.13 Regarding the postsupplementation samples, the 3months of oral iron supplementation produced a significant increase in ferritin concentrations in virtually all of the women, irrespective of their initial iron status. 

Phrase: "Thus,"

Phrase: "this concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "can"

Phrase: "be"

Phrase: "used as a cut-off value"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C1442160:Cutoff [Functional Concept]
   753   C0000925:Cut [Injury or Poisoning]
   753   C1273517:used [Finding]
   753   C1522609:Value [Quantitative Concept]
   753   C1883724:CUT [Phenomenon or Process]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "for both men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "and"

Phrase: "women.13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "Regarding"

Phrase: "the postsupplementation samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "the 3months of oral iron supplementation"

Phrase: "produced"

Phrase: "a significant increase in ferritin concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in virtually"

Phrase: "all of the women,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043210:Women [Population Group]
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]

Phrase: "irrespective of their initial iron status."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.84: Four of the 17women with IDE and very low initial ferritin concentrations emerged from the trial with ferritin concentrations of 17to 18g/L and normalized sTfR. 

Phrase: "Four of the 17women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205450:Four [Quantitative Concept]

Phrase: "with IDE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014819:Erythropoiesis [Cell Function,Organ or Tissue Function]
   755 E C0312829:Erythropoietic [Functional Concept]

Phrase: "and"

Phrase: "very low initial ferritin concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   836   C2827826:Initial Concentration [Quantitative Concept]
   804   C0086045:Concentrations [Mental Process]
   771 E C1446561:Concentration [Quantitative Concept]
   721 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "emerged from the trial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0008976:Trial [Research Activity]

Phrase: "with ferritin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 17to 18g/L"

Phrase: "and"

Phrase: "normalized sTfR."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0428545:Serum transferrin [Laboratory Procedure]
   861   C1318186:serum transferrin [Laboratory or Test Result]
   861   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   861   C1619635:Transferrin Receptor [Immunologic Factor]
   812   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1442762:TRANSFERRIN [Gene or Genome]
   729 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.85: Excluding these four subjects, the lower limit of the 95% reference interval for women in samples taken after supplementation was also 22g/L (90% confidence interval, 21to 24g/L). 

Phrase: "Excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "these four subjects,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "the lower limit of the 95% reference interval"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   744   C0439801:limit [Functional Concept]
   744   C0441994:Lower [Spatial Concept]
   744   C1548802:Lower [Body Location or Region]
   744   C1549649:Limit [Idea or Concept]
   744   C2003888:Lower [Activity]
   744   C2349209:Limit [Conceptual Entity]
   711 E C0205251:low [Qualitative Concept]
   711 E C1299352:Low [Qualitative Concept]
   711 E C1550472:low [Idea or Concept]

Phrase: "for women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "in samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "taken after supplementation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]

Phrase: "was"

Phrase: "also 22g/L (90% confidence interval,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0009667:Confidence Interval [Quantitative Concept]
   799   C0237529:Confidence [Mental Process]
   799   C1272706:Interval [Temporal Concept]
   799   C1552654:Interval [Idea or Concept]
   799   C1552713:Interval [Intellectual Product]
   799   C1704725:Confidence [Qualitative Concept]
   799   C1704726:Confidence [Mental Process]
   727 E C0558095:Confident [Individual Behavior]

Phrase: "21to 24g/L)."
Processing 00000000.tx.86: The restoration of the storage compartment is known to be initiated only after the immediate demand for iron is met and any losses of the functional compartment halted. 

Phrase: "The restoration of the storage compartment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449982:Restoration [Intellectual Product]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "only after the immediate demand"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205171:Only [Quantitative Concept]
   760   C0205253:Immediate [Temporal Concept]
   760   C0205548:Immediate [Temporal Concept]
   760   C0441516:Demand [Therapeutic or Preventive Procedure]
   760   C0699784:demand [Idea or Concept]
   760   C1720467:Only [Intellectual Product]

Phrase: "for iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "is"

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "and"

Phrase: "any losses of the functional compartment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1517945:Loss [Quantitative Concept]

Phrase: "halted."
Processing 00000000.tx.87: Therefore, the supplementation used in this study seems to have been insufficient for complete replenishment of the iron deficit in subjects with functional depletion. 

Phrase: "Therefore,"

Phrase: "the supplementation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242297:Supplementation [Therapeutic or Preventive Procedure]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "insufficient for complete replenishment of the iron deficit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205412:Insufficient [Qualitative Concept]
   744   C0231180:Insufficient [Qualitative Concept]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with functional depletion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]
Processing 00000000.tx.88: The data from sTfR measurements give a clearer picture of functional iron status than ferritin measurements. 

Phrase: "The data from sTfR measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a clearer picture of functional iron status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441468:picture [Manufactured Object]
   748   C0441469:Picture [Manufactured Object]

Phrase: "than ferritin measurements."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0373607:Ferritin measurement [Laboratory Procedure]
   861   C0242485:measurements [Functional Concept]
Processing 00000000.tx.89: sTfR concentrations remain unaffected by any active acute-phase reactants, which has made sTfR measurement an attractive tool for the differential diagnosis of IDA.16-18 Its day-to-day variation is more acceptable than that of the conventionally used indices of functional iron status, such as transferrin saturation.45 Although sTfR concentrations are known to reflect the degree of depletion of the functional compartment well before IDA develops, most clinical experience comes from settings where reference limits have been set to diagnose ID in patients already anemic. 

Phrase: "sTfR concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   886   C0683149:serum concentration [Quantitative Concept]
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "remain"

Phrase: "unaffected by any active acute-phase reactants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986417:Unaffected [Conceptual Entity]

Phrase: "which"

Phrase: "has"

Phrase: "made sTfR measurement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   888   C0428545:Serum transferrin measurement [Laboratory Procedure]
   853   C0202105:Transferrin measurement [Laboratory Procedure]
   804   C0242485:Measurement [Functional Concept]

Phrase: "an attractive tool for the differential diagnosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0336791:Tool [Manufactured Object]
   748   C2827396:Tool [Manufactured Object]

Phrase: "of IDA.16-18"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   884   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   840   C0041782:Deficiency Anemia [Disease or Syndrome]
   840   C0240066:Iron deficiency [Disease or Syndrome]
   804   C0002871:Anaemia [Disease or Syndrome]
   804   C0011155:Deficiency [Functional Concept]
   804   C0162429:Deficiency [Disease or Syndrome]
   804   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0376520:Iron [Inorganic Chemical]
   804   C1000483:Anemia [Plant]
   804   C1166521:iron [Pharmacologic Substance]
   804   C1623416:deficiency [Qualitative Concept]
   733 E C0857322:anaemic [Finding]
   733 E C1636779:% deficient [Quantitative Concept]

Phrase: "Its day-to-day variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "more acceptable than that of the conventionally used indices of functional iron status,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C1879533:Acceptable [Qualitative Concept]
   735   C3539083:Acceptable [Qualitative Concept]

Phrase: "such as transferrin saturation.45"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C1277709:Transferrin saturation [Laboratory Procedure]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0522534:Saturation [Phenomenon or Process]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   755 E C1705188:SATURATED [Quantitative Concept]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Although"

Phrase: "sTfR concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   886   C0683149:serum concentration [Quantitative Concept]
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the degree of depletion of the functional compartment well"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0441889:Degree [Qualitative Concept]
   742   C0449286:Degree [Quantitative Concept]
   742   C0542560:Degree [Intellectual Product]
   742   C1561545:degree [Quantitative Concept]
   742   C2348088:Degree [Quantitative Concept]

Phrase: "before"

Phrase: "IDA"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   901   C0041782:Deficiency Anemia [Disease or Syndrome]
   901   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0002871:Anaemia [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1000483:Anemia [Plant]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C0857322:anaemic [Finding]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "develops"

Phrase: ","

Phrase: "most clinical experience"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237607:experience [Mental Process]
   861   C0596545:Experience [Mental Process]

Phrase: "comes from settings where"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0542559:setting [Functional Concept]
   737   C1318139:{Setting} [Quantitative Concept]

Phrase: "reference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "limits"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0439801:limits [Functional Concept]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]
   916 E C3542948:Limited [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "diagnose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:diagnose [Finding]

Phrase: "ID in patients"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0240066:Iron deficiency [Disease or Syndrome]
   770   C0011155:Deficiency [Functional Concept]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0376520:Iron [Inorganic Chemical]
   770   C1166521:iron [Pharmacologic Substance]
   770   C1623416:deficiency [Qualitative Concept]

Phrase: "already anemic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0857322:anaemic [Finding]

Phrase: "."
Processing 00000000.tx.90: We wished to modify the normal range of sTfR measurements to permit the detection of the inception of IDE. 

Phrase: "We"

Phrase: "wished"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1423524:WISH [Gene or Genome]
   966   C3273411:WISH [Gene or Genome]
   966   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the normal range of sTfR measurements to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0086715:Normal Range [Quantitative Concept]
   742   C0205307:Normal [Qualitative Concept]
   742   C0439166:% normal [Quantitative Concept]
   742   C1514721:Range [Quantitative Concept]
   742   C2347086:% Normal [Quantitative Concept]
   742   C2348147:Range [Quantitative Concept]
   742   C3542016:Range [Intellectual Product]

Phrase: "permit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "the detection of the inception of IDE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.91: sTfR concentrations exceeding 2.75mg/L (90% confidence interval, 2.34to 2.84mg/L), but not 3.6mg/L (90% confidence interval, 3.26to 3.72mg/L; measured using the IDeA method of Orion Diagnostica) were deemed to define a subgroup of individuals having depletion of the functional iron compartment leading to IDE. 

Phrase: "sTfR concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   886   C0683149:serum concentration [Quantitative Concept]
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "exceeding"

Phrase: "2.75mg/L (90% confidence interval,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0009667:Confidence Interval [Quantitative Concept]
   799   C0237529:Confidence [Mental Process]
   799   C1272706:Interval [Temporal Concept]
   799   C1552654:Interval [Idea or Concept]
   799   C1552713:Interval [Intellectual Product]
   799   C1704725:Confidence [Qualitative Concept]
   799   C1704726:Confidence [Mental Process]
   727 E C0558095:Confident [Individual Behavior]

Phrase: "2.34to 2.84mg/L),"

Phrase: "but"

Phrase: "not 3.6mg/L (90% confidence interval,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   818   C0009667:Confidence Interval [Quantitative Concept]
   795   C0237529:Confidence [Mental Process]
   795   C1272706:Interval [Temporal Concept]
   795   C1552654:Interval [Idea or Concept]
   795   C1552713:Interval [Intellectual Product]
   795   C1704725:Confidence [Qualitative Concept]
   795   C1704726:Confidence [Mental Process]
   724 E C0558095:Confident [Individual Behavior]

Phrase: "3.26to 3.72mg/L"

Phrase: ";"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the IDeA method of Orion Diagnostica"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "deemed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "a subgroup of individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1079230:subgroup [Virus]
   770   C1515021:Subgroup [Classification]

Phrase: "having"

Phrase: "depletion of the functional iron compartment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0333668:Depletion [Functional Concept]

Phrase: "leading to IDE."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   760   C0011155:Deficient [Functional Concept]
   760   C0014819:Erythropoiesis [Cell Function,Organ or Tissue Function]
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0332152:Leading [Temporal Concept]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1522538:Leading [Functional Concept]
   760   C1636779:% deficient [Quantitative Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.92: For comparison, in a previous study,19 an sTfR concentration of 3.6mg/L was identified as an optimal cutoff value for IDA. 

Phrase: "For comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "in a previous study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "19"

Phrase: "an sTfR concentration of 3.6mg/L"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0683149:concentration serum [Quantitative Concept]
   742   C0086045:Concentration [Mental Process]
   742   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "identified as an optimal cutoff value"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205396:Identified [Qualitative Concept]
   753   C1442160:Cutoff [Functional Concept]
   753   C1522609:Value [Quantitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C2698651:Optimal [Qualitative Concept]

Phrase: "for IDA."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   901   C0041782:Deficiency Anemia [Disease or Syndrome]
   901   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0002871:Anaemia [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1000483:Anemia [Plant]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C0857322:anaemic [Finding]
   755 E C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.93: Supplementation induced a significant decrease in sTfR in all 17women with initial values >2.75 mg/L, whereas little change was seen in the other women or any men with initial values <2.75 mg/L. 

Phrase: "Supplementation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242297:Supplementation [Therapeutic or Preventive Procedure]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a significant decrease in sTfR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "in all 17women"

Phrase: "with initial values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: ">2.75 mg/L,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439268:mg/L [Quantitative Concept]

Phrase: "whereas"

Phrase: "little change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "seen in the"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "other women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "or"

Phrase: "any men with initial values"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0025266:Men [Population Group]
   726 E C0024554:MAN [Finding]
   726 E C0086418:Man [Human]

Phrase: "<2.75 mg/L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439268:mg/L [Quantitative Concept]
Processing 00000000.tx.94: This observation supports earlier findings about the stability of sTfR, which does not begin to increase until the development of true tissue ID. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "earlier findings about the stability of sTfR,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   742   C2607943:findings [Functional Concept]
   742   C2926606:Findings [Clinical Attribute]
   742   C3539655:Findings [Intellectual Product]
   708 E C0037088:Finding [Sign or Symptom]
   708 E C0243095:Finding [Finding]
   708 E C2825141:Finding [Finding]

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase until the development of true tissue ID."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   764   C0240066:Iron deficiency [Disease or Syndrome]
   762   C0178679:tissue development [Organ or Tissue Function]
   742   C0011155:Deficiency [Functional Concept]
   742   C0040300:Tissue [Tissue]
   742   C0162429:Deficiency [Disease or Syndrome]
           Acquired deficiency
   742   C0205238:True [Qualitative Concept]
   742   C0243107:development [Physiologic Function]
   742   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0376520:Iron [Inorganic Chemical]
   742   C0442805:Increase [Functional Concept]
   742   C0678723:Development [Organism Function]
   742   C1166521:iron [Pharmacologic Substance]
   742   C1527148:Development [Functional Concept]
   742   C1547928:Tissue [Intellectual Product]
   742   C1623416:deficiency [Qualitative Concept]
   720   C0860976:increased iron [Finding]
Processing 00000000.tx.95: The difference in sTfR levels between men and women completely disappeared during the study, indicating that the initial difference might be explained by IDE present only in the women of our population sample. 

Phrase: "The difference in sTfR levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "between men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "and"

Phrase: "women completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "disappeared during the study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "indicating"

Phrase: "that"

Phrase: "the initial difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "explained by IDE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0011155:Deficient [Functional Concept]
   760   C0014819:Erythropoiesis [Cell Function,Organ or Tissue Function]
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1636779:% deficient [Quantitative Concept]

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only in the women of our population sample."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0032659:Population [Quantitative Concept]
   744   C0043210:Women [Population Group]
   744   C0205171:Only [Quantitative Concept]
   744   C0370003:Sample [Substance]
   744   C1257890:Population [Population Group]
   744   C1720467:Only [Intellectual Product]
   744   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.96: Consequently, the 95% reference interval, as suggested by the results obtained after supplementation, became narrower and virtually identical for both men and women. 

Phrase: "Consequently,"

Phrase: "the 95% reference interval,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0086715:reference interval [Quantitative Concept]
   827   C1272706:Interval [Temporal Concept]
   827   C1514811:Reference [Idea or Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1706462:Reference [Conceptual Entity]

Phrase: "as"

Phrase: "suggested by the results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C1705535:Suggest [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "obtained after supplementation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "became"

Phrase: "narrower"

Phrase: "and"

Phrase: "virtually identical for both men"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]

Phrase: "and"

Phrase: "women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]
Processing 00000000.tx.97: This is in agreement with previous studies, which have found similar sTfR concentrations in men and women.20,31,46 In our population, therefore, the elevated presupplementation range of sTfR was likely due to subclinical ID. 

Phrase: "This"

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with previous studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "which"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "similar sTfR concentrations in men"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0683149:concentrations serum [Quantitative Concept]
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "women.20,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "46 In our population,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "therefore,"

Phrase: "the elevated presupplementation range of sTfR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]

Phrase: "was"

Phrase: "likely due to subclinical ID."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0240066:Iron deficiency [Disease or Syndrome]
   790   C0678226:Due to [Functional Concept]
           due
   753   C0011155:Deficiency [Functional Concept]
   753   C0162429:Deficiency [Disease or Syndrome]
   753   C0205211:Subclinical [Qualitative Concept]
   753   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0332148:Likely [Qualitative Concept]
   753   C0376520:Iron [Inorganic Chemical]
   753   C0750492:Likely [Idea or Concept]
   753   C1166521:iron [Pharmacologic Substance]
   753   C1623416:deficiency [Qualitative Concept]
   753   C3146286:Due [Idea or Concept]
Processing 00000000.tx.98: The sTfR/log ferritin ratio (TfR-F Index) has been shown to distinguish between iron-replete and iron-deplete anemic patients effectively, yet its value in diagnosing nonanemic ID remains to be verified.16 In the present study, the supplementation-induced change was made most apparent by using the TfR-F Index, indicating that the nonanemic stages of ID are readily detectable using this index. 

Phrase: "The sTfR/log ferritin ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0456603:Ratio [Quantitative Concept]
   799   C1547037:Ratio [Intellectual Product]
   709   C0696113:Serum ferritin [Laboratory Procedure]

Phrase: "(TfR-F Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distinguish between iron-replete"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0376520:Iron [Inorganic Chemical]
   770   C1166521:iron [Pharmacologic Substance]

Phrase: "and"

Phrase: "iron-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "deplete"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   944   C1550032:Unload [Idea or Concept]
   944   C1880497:Empty [Qualitative Concept]
   944   C1996907:Emptying [Activity]
   916 E C0333668:Depleted [Functional Concept]

Phrase: "anemic patients effectively,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "yet"

Phrase: "its value in diagnosing nonanemic ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1522609:Value [Quantitative Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "verified.16 In the present study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
   753   C0557651:Study [Manufactured Object]
   753   C1711411:Verified [Functional Concept]
   753   C2603343:Study [Research Activity]

Phrase: "the supplementation-induced change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0392747:Change [Functional Concept]
   827   C0443172:change [Quantitative Concept]
   827   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "most apparent by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750489:apparent [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TfR-F Index,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the nonanemic stages of ID"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1306673:Stages [Qualitative Concept]
   719 E C0205390:Stage [Temporal Concept]
   719 E C1300072:Stage [Clinical Attribute]

Phrase: "are"

Phrase: "readily detectable"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this index."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0918012:Index [Intellectual Product]
  1000   C1552854:index [Idea or Concept]
  1000   C1637833:% index [Quantitative Concept]
Processing 00000000.tx.99: Similar supplementation-induced changes have been observed by Simmons et al.36 The TfR-F Index can distinguish storage iron depletion (stage I) from IDE (stage II), such that separate decision limits could be derived in the present study: a ratio of 1.8(90% confidence interval, 1.55to 1.99) or greater for storage iron depletion and 2.2(90% confidence interval, 1.81 to 2.53) or greater for IDE (Fig 1). 

Phrase: "Similar supplementation-induced changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0392747:changes [Functional Concept]
   812   C0443172:changes [Quantitative Concept]
   779 E C1705241:Change [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "observed by Simmons et al.36"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1441672:Observed [Functional Concept]

Phrase: "The TfR-F Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "can"

Phrase: "distinguish"

Phrase: "storage iron depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333668:Depletion [Functional Concept]

Phrase: "(stage I) from IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441766:Stage I [Intellectual Product]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(stage II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441767:Stage II [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "such"

Phrase: "that separate decision limits"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0439801:limits [Functional Concept]
   793 E C1549649:Limit [Idea or Concept]
   793 E C2349209:Limit [Conceptual Entity]
   743 E C3542948:Limited [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "derived in the present study"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1441547:Derived [Qualitative Concept]
   760   C2603343:Study [Research Activity]
   760   C3245521:derived [Idea or Concept]

Phrase: ":"

Phrase: "a ratio of 1.8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "(90% confidence interval,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "1.55to 1.99"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "or"

Phrase: "greater for storage iron depletion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "and"

Phrase: "2.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(90% confidence interval,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "1.81 to 2.53"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0580272:1/2 [Intellectual Product]
   797   C1519043:1-2 [Research Activity]
   760   C2827734:1+ [Quantitative Concept]
   760   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "or"

Phrase: "greater for IDE"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "(Fig 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.100: One subject considered normal presented with a combination of borderline normal values of ferritin (22g/L) and sTfR (2.43mg/L), but a slightly elevated TfR-F Index (1.81) in the presupplementation sample. 

Phrase: "One subject considered normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205307:Normal [Qualitative Concept]
   812   C0439166:% normal [Quantitative Concept]
   812   C2347086:% Normal [Quantitative Concept]

Phrase: "presented with a combination of borderline normal values of ferritin"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   760   C0086715:Normal Values [Quantitative Concept]
   757   C0860973:ferritin normal [Finding]
   739   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0042295:Values [Qualitative Concept]
   739   C0205189:Borderline [Qualitative Concept]
   739   C0205195:Combination [Qualitative Concept]
   739   C0205307:Normal [Qualitative Concept]
   739   C0439166:% normal [Quantitative Concept]
   739   C0449450:Presented [Idea or Concept]
   739   C1947911:Combination [Physical Object]
   739   C2347086:% Normal [Quantitative Concept]
   706 E C0150312:Present [Quantitative Concept]
   706 E C1522609:Value [Quantitative Concept]

Phrase: "(22g/L)"

Phrase: "and"

Phrase: "sTfR"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(2.43mg/L),"

Phrase: "but"

Phrase: "a slightly elevated TfR-F Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0918012:Index [Intellectual Product]
   804   C1552854:index [Idea or Concept]
   804   C1637833:% index [Quantitative Concept]

Phrase: "(1.81"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "in the presupplementation sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.101: This might indicate that in borderline cases, when the results of sTfR and ferritin assays are ambiguous, the TfR-F Index is more sensitive in the detection of iron-deficient states. 

Phrase: "This"

Phrase: "might"

Phrase: "indicate"

Phrase: "that in borderline cases,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205189:Borderline [Qualitative Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "when"

Phrase: "the results of sTfR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "and"

Phrase: "ferritin assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "are"

Phrase: "ambiguous,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1549102:Ambiguous [Organism Attribute]
  1000   C3539086:Ambiguous [Intellectual Product]
   928 E C2346729:Ambiguity [Qualitative Concept]

Phrase: "the TfR-F Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "is"

Phrase: "more sensitive in the detection of iron-deficient states."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332324:Sensitive [Functional Concept]
   742   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.102: The role of the individual tests of serum iron, serum transferrin, and transferrin saturation should be reevaluated because of their unpredictable variability and relative insensitivity.7,14,16,47,48 Our findings indicate that sTfR measurement could replace these procedures in the routine testing of ID, as the subclinical ID present in our study population remained undetected by these other methods, and the changes induced by supplementation were sporadic and inconsistent (Table 1). 

Phrase: "The role of the individual tests of serum iron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "serum transferrin,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0428545:Serum transferrin [Laboratory Procedure]
  1000   C1318186:serum transferrin [Laboratory or Test Result]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "transferrin saturation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1277709:Transferrin saturation [Laboratory Procedure]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0522534:Saturation [Phenomenon or Process]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   789 E C1705188:SATURATED [Quantitative Concept]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "should"

Phrase: "be"

Phrase: "reevaluated because of their unpredictable variability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2827666:Variability [Conceptual Entity]

Phrase: "and"

Phrase: "relative insensitivity.7,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C0237677:Insensitivity [Finding]
   827   C1547039:*Relative [Quantitative Concept]

Phrase: "14,"

Phrase: "16,"

Phrase: "47,"

Phrase: "48"

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that sTfR measurement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0428545:Serum transferrin measurement [Laboratory Procedure]
   875   C0202105:Transferrin measurement [Laboratory Procedure]
   812   C0242485:Measurement [Functional Concept]

Phrase: "could"

Phrase: "replace"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554078:Replace [Idea or Concept]

Phrase: "these procedures in the routine testing of ID,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   745   C1298805:Routine procedure [Therapeutic or Preventive Procedure]
   742   C0025664:procedures [Intellectual Product]
   742   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   742   C2700391:procedures [Activity]
   708 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   708 E C3274430:PROCEDURE [Health Care Activity]
   708 E C3538935:Procedure [Idea or Concept]
   708 E C3539779:Procedure [Intellectual Product]

Phrase: "as"

Phrase: "the subclinical ID present in our study population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]

Phrase: "remained"

Phrase: "undetected by these"

Phrase: "other methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "the changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "induced by supplementation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induced [Functional Concept]
   790   C0242297:Supplementation [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "sporadic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "and"

Phrase: "inconsistent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442809:Inconsistent [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.103: This study was undertaken in an attempt to characterize the different stages of ID by means of serum ferritin, sTfR, and TfR-F Index determinations. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "undertaken in an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1516084:Attempt [Event]

Phrase: "characterize"

Phrase: "the different stages of ID"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1306673:Stages [Qualitative Concept]
   719 E C0205390:Stage [Temporal Concept]
   719 E C1300072:Stage [Clinical Attribute]

Phrase: "by means of serum ferritin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0696113:Serum ferritin [Laboratory Procedure]
   861   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "sTfR,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "TfR-F Index determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0680730:determinations [Governmental or Regulatory Activity]
   779 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.104: A relatively large number of women of childbearing age were intentionally enrolled to permit inclusion of a larger proportion of potential subjects with subclinical ID. 

Phrase: "A relatively large number of women of childbearing age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "intentionally"

Phrase: "enrolled"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "permit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "inclusion of a larger proportion of potential subjects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1512693:Inclusion [Qualitative Concept]

Phrase: "with subclinical ID."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.105: Therefore, the data presented in this study offer limited epidemiologic information. 

Phrase: "Therefore,"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented in this study"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0449450:Presented [Idea or Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "offer"

Phrase: "limited epidemiologic information."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]
Processing 00000000.tx.106: In our opinion, the presence of IDE could be disclosed by sTfR concentrations, whereas Hb determination is applicable to the detection of IDA. 

Phrase: "In our opinion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871010:opinion [Mental Process]

Phrase: "the presence of IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "be"

Phrase: "disclosed by sTfR concentrations,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0428545:Serum transferrin [Laboratory Procedure]
   790   C1318186:serum transferrin [Laboratory or Test Result]
   790   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   790   C1619635:Transferrin Receptor [Immunologic Factor]
   783   C0683149:concentrations serum [Quantitative Concept]
   753   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C0229671:Serum [Body Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1442762:TRANSFERRIN [Gene or Genome]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "whereas"

Phrase: "Hb determination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0518015:Haemoglobin determination, NOS [Laboratory Procedure]
   861   C1148554:determination [Laboratory Procedure]

Phrase: "is"

Phrase: "applicable to the detection of IDA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1272460:applicable [Qualitative Concept]
   744   C1706839:Applicable [Qualitative Concept]
Processing 00000000.tx.107: The detection of reduced ferritin concentrations, on the other hand, could indicate an increased risk of progressive ID, and together with sTfR, distinguish between the two subclinical phases of ID. 

Phrase: "The detection of reduced ferritin concentrations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "could"

Phrase: "indicate"

Phrase: "an increased risk of progressive ID,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0860976:increased iron [Finding]
   748   C0035647:Risk [Qualitative Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   728   C0162429:Acquired deficiency [Disease or Syndrome]

Phrase: "and together with sTfR,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0428545:Serum transferrin [Laboratory Procedure]
   790   C1318186:serum transferrin [Laboratory or Test Result]
   790   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   790   C1619635:Transferrin Receptor [Immunologic Factor]
   753   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0229671:Serum [Body Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1442762:TRANSFERRIN [Gene or Genome]
   753   C1515981:And [Idea or Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1883357:Together [Qualitative Concept]

Phrase: "distinguish between the two subclinical phases of ID."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   764   C0240066:Iron deficiency [Disease or Syndrome]
   742   C0011155:Deficiency [Functional Concept]
   742   C0162429:Deficiency [Disease or Syndrome]
   742   C0205211:Subclinical [Qualitative Concept]
   742   C0205448:Two [Quantitative Concept]
   742   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0376520:Iron [Inorganic Chemical]
   742   C0585064:Phases [Temporal Concept]
   742   C1067936:Phasis [Eukaryote]
   742   C1166521:iron [Pharmacologic Substance]
   742   C1623416:deficiency [Qualitative Concept]
   708 E C0205390:Phase [Temporal Concept]
Processing 00000000.tx.108: In certain situations, emphasizing the importance of sTfR rather than the Hb alone in the diagnostic algorithm might contribute to a more effective preventive approach: a clinically silent ID could be detected when the need for compensatory mechanisms arises, ie, well before IDA develops. 

Phrase: "In certain situations,"

Phrase: "emphasizing"

Phrase: "the importance of sTfR"

Phrase: "rather than"

Phrase: "the Hb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone in the diagnostic algorithm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205171:Alone [Quantitative Concept]
   760   C0439044:alone [Finding]
   760   C0679994:alone [Group Attribute]

Phrase: "might"

Phrase: "contribute to a more effective preventive approach"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0445202:preventive [Functional Concept]
   748   C0449445:Approach [Spatial Concept]
   748   C1280519:effective [Qualitative Concept]
   748   C1456501:Preventive [Qualitative Concept]
   748   C1704419:Effective [Qualitative Concept]
   748   C1880177:Contribute [Activity]

Phrase: ":"

Phrase: "a clinically silent ID"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0240066:Iron deficiency [Disease or Syndrome]
   812   C0011155:Deficiency [Functional Concept]
   812   C0162429:Deficiency [Disease or Syndrome]
   812   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0376520:Iron [Inorganic Chemical]
   812   C1166521:iron [Pharmacologic Substance]
   812   C1623416:deficiency [Qualitative Concept]
   741 E C1636779:% deficient [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "the need for compensatory mechanisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027552:Need [Qualitative Concept]
   760   C0686904:need [Functional Concept]

Phrase: "arises"

Phrase: ","

Phrase: "ie"

Phrase: ","

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "before"

Phrase: "IDA"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   901   C0041782:Deficiency Anemia [Disease or Syndrome]
   901   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0002871:Anaemia [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1000483:Anemia [Plant]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C0857322:anaemic [Finding]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "develops."
Processing 00000000.tx.109: The limited availability of dietary iron almost never seems to be the only explanation for ID in older children, adult men, and postmenopausal women. 

Phrase: "The limited availability of dietary iron almost never"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the only explanation for ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanation [Intellectual Product]

Phrase: "in older children,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C1455726:Older child [Age Group]
   966 E C2919014:OLD_CHILD [Idea or Concept]
   861   C0008059:Children [Age Group]
   861   C0680063:Children [Family Group]

Phrase: "adult men,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0025266:Men [Population Group]
   827 E C0024554:MAN [Finding]
   827 E C0086418:Man [Human]

Phrase: "and"

Phrase: "postmenopausal women."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043210:Women [Population Group]
   861   C0232970:postmenopausal [Temporal Concept]
Processing 00000000.tx.110: Therefore, further investigation is often promptly indicated to disclose the underlying cause of ID. 

Phrase: "Therefore,"

Phrase: "further investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "is"

Phrase: "often promptly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332183:Often [Temporal Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disclose"

Phrase: "the underlying cause of ID."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.111: In certain situations where an increase in iron requirements can be expected, it might be useful to regard elevated sTfR concentrations as the manifestation of true ID, as an elevated concentration represents IDE. 

Phrase: "In certain situations where"

Phrase: "an increase in iron requirements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "it"

Phrase: "might"

Phrase: "be"

Phrase: "useful to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0042153:use [Functional Concept]
   789   C0457083:Use [Functional Concept]
   789   C1947944:Use [Intellectual Product]

Phrase: "regard"

Phrase: "elevated sTfR concentrations as the manifestation of true ID,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   751   C0683149:concentrations serum [Quantitative Concept]
   736   C0086045:Concentrations [Mental Process]
   703 E C1446561:Concentration [Quantitative Concept]

Phrase: "as"

Phrase: "an elevated concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "IDE."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014819:Erythropoiesis [Cell Function,Organ or Tissue Function]
   755 E C0312829:Erythropoietic [Functional Concept]
Processing 00000000.tx.112: This use of sTfR measurement offers a particular advantage over ferritin determination in physiologic conditions, in which depletion of the storage compartment is highly prevalent, such as infancy, early childhood, adolescence, and pregnancy. 

Phrase: "This use of sTfR measurement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "offers"

Phrase: "a particular advantage over ferritin determination"

Phrase: "in physiologic conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "in which depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333668:Depletion [Functional Concept]

Phrase: "of the storage compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "is"

Phrase: "highly prevalent,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0033105:Prevalence [Quantitative Concept]
   789   C0220900:prevalence [Quantitative Concept]

Phrase: "such as infancy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231330:Infancy [Temporal Concept]

Phrase: "early childhood,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0599196:Early Childhood [Temporal Concept]
   861   C0231335:Childhood [Temporal Concept]

Phrase: "adolescence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001578:Adolescence [Age Group]
   928 E C0205653:Adolescent [Age Group]

Phrase: "and"

Phrase: "pregnancy."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]
Processing 00000000.tx.113: In these conditions, ferritin concentrations are usually close to the limit of ID, and monitoring sTfR would show differences in functional iron status more accurately. 

Phrase: "In these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "ferritin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "are"

Phrase: "usually"

Phrase: "close to the limit of ID,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0240066:Iron deficiency [Disease or Syndrome]
   748   C0011155:Deficiency [Functional Concept]
   748   C0162429:Deficiency [Disease or Syndrome]
   748   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0376520:Iron [Inorganic Chemical]
   748   C0439801:limit [Functional Concept]
   748   C0587267:Close [Functional Concept]
   748   C1166521:iron [Pharmacologic Substance]
   748   C1549649:Limit [Idea or Concept]
   748   C1623416:deficiency [Qualitative Concept]
   748   C2349209:Limit [Conceptual Entity]

Phrase: "and"

Phrase: "monitoring sTfR"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0428545:Serum transferrin [Laboratory Procedure]
   861   C1318186:serum transferrin [Laboratory or Test Result]
   861   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   861   C1619635:Transferrin Receptor [Immunologic Factor]
   812   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1442762:TRANSFERRIN [Gene or Genome]
   729 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "would"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "differences in functional iron status more accurately."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.114: The combined use of ferritin, sTfR, and Hb determinations, along with the TfR-F Index, facilitates the accurate determination of the iron status of any given patient. 

Phrase: "The combined use of ferritin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "sTfR,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Hb determinations,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0518015:Haemoglobin determination, NOS [Laboratory Procedure]
   861   C0680730:determinations [Governmental or Regulatory Activity]
   827 E C1148554:determination [Laboratory Procedure]

Phrase: "along with the TfR-F Index,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "facilitates"

Phrase: "the accurate determination of the iron status of any given patient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0184762:Patient status determination [Health Care Activity]
   738   C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.115: The clinical condition of the individual patient, however, dictates which measurement should be emphasized for the diagnosis of ID and whether the diagnosis of ID warrants monitoring, dietary counseling, iron therapy, or other measures.  

Phrase: "The clinical condition of the individual patient,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0683521:condition patient [Finding]
   748   C0012634:condition [Disease or Syndrome]
   748   C0205210:Clinical [Qualitative Concept]
   748   C0348080:Condition [Qualitative Concept]
   748   C1705253:Condition [Conceptual Entity]

Phrase: "however,"

Phrase: "dictates"

Phrase: "which measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "should"

Phrase: "be"

Phrase: "emphasized for the diagnosis of ID"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0240066:Iron deficiency [Disease or Syndrome]
   748   C0011155:Deficiency [Functional Concept]
   748   C0011900:Diagnosis [Finding]
   748   C0162429:Deficiency [Disease or Syndrome]
   748   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0376520:Iron [Inorganic Chemical]
   748   C1166521:iron [Pharmacologic Substance]
   748   C1623416:deficiency [Qualitative Concept]
   748   C1704338:diagnosis [Qualitative Concept]
   748   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "whether"

Phrase: "the diagnosis of ID warrants monitoring,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0011900:Diagnosis [Finding]
   748   C1704338:diagnosis [Qualitative Concept]
   748   C1704656:DIAGNOSIS [Research Activity]

Phrase: "dietary counseling,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0204932:dietary counseling [Educational Activity]
   861   C0010210:Counseling [Health Care Activity]
   861   C0341618:Counselling [Professional or Occupational Group]
   861   C0740209:Counseling NOS [Finding]

Phrase: "iron therapy,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C1363945:Therapy [Finding]

Phrase: "or"

Phrase: "other measures."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0079809:Measures [Quantitative Concept]
  1000   C1879489:Measures [Functional Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.116: FOOTNOTES  Submitted December 29,1997; 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "December 29,"

Phrase: "1997"

Phrase: ";"
Processing 00000000.tx.117: accepted June 5,1998.  

Phrase: "accepted June 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1998."
Processing 00000000.tx.118: Address reprint requests to Pauli Suominen, MD, Central Laboratory, Turku University Central Hospital, PL 52,FIN-20521, Turku, Finland; 

Phrase: "Address reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Pauli Suominen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0686900:request [Functional Concept]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]

Phrase: "MD,"

Phrase: "Central Laboratory,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880016:Central Laboratory [Organization]
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "Turku University Central Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   875   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "PL 52,"

Phrase: "FIN-20521,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230113:Fin [Body Part, Organ, or Organ Component]

Phrase: "Turku,"

Phrase: "Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: ";"
Processing 00000000.tx.119: e-mail: pausuo{at}utu.fi .  The publication costs of this article were defrayed in part by page charge payment. 

Phrase: "e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "pausuo{at}utu.fi ."

Phrase: "The publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034036:Publication [Intellectual Product,Manufactured Object]
  1000   C0034037:Publication [Occupational Activity]
  1000   C1704324:Publication [Intellectual Product]

Phrase: "costs of this article"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010186:Cost [Quantitative Concept]
   770   C0220812:Costs [Quantitative Concept]
   770   C1706852:Article [Intellectual Product]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by page charge payment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0220808:payment [Quantitative Concept]
   827   C0680264:payment [Quantitative Concept]
Processing 00000000.tx.120: This article must therefore be hereby marked "advertisement" is accordance with 18U.S.C. section 1734 solely to indicate this fact.  

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "is"

Phrase: "accordance with 18U.S.C. section 1734 solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.121: REFERENCES Abstract Introduction Methods Results Discussion References 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0557061:Discussion [Therapeutic or Preventive Procedure]
   804   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.122: Dallman PR, Siimes MA, Stekel A: Iron deficiency in infancy and childhood. 

Phrase: "Dallman PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Siimes MA,"

Phrase: "Stekel A"

Phrase: ":"

Phrase: "Iron deficiency in infancy"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0240066:Iron deficiency [Disease or Syndrome]
   770   C0011155:Deficiency [Functional Concept]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0376520:Iron [Inorganic Chemical]
   770   C1166521:iron [Pharmacologic Substance]
   770   C1623416:deficiency [Qualitative Concept]

Phrase: "and"

Phrase: "childhood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231335:Childhood [Temporal Concept]
Processing 00000000.tx.123: Am J Clin Nutr 33:86, 1980[Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "Am"

Phrase: "J Clin Nutr 33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "86,"

Phrase: "1980"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.124: Expert Scientific Working Group: Summary of a report on assessment of the iron nutritional status of the United States population. 

Phrase: "Expert Scientific Working Group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C1883562:Working Group [Population Group]
   812   C0043227:Working [Occupational Activity]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: ":"

Phrase: "Summary of a report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0242482:Summary Report [Intellectual Product]
   770   C1552616:summary [Intellectual Product]
   770   C1706244:Summary [Intellectual Product]

Phrase: "on assessment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1261322:Assessment [Health Care Activity]
  1000   C1516048:Assessment [Activity]

Phrase: "of the iron nutritional status"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0392209:Nutritional status [Organism Attribute]
   827   C0449438:Status [Qualitative Concept]
   827   C1521739:Nutritional [Qualitative Concept]
   827   C2707262:Nutritional [Clinical Attribute]

Phrase: "of the United States population."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0041703:United States [Geographic Area]
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
   827   C1301808:states [Geographic Area]
   793   C0166872:unite [Biomedical or Dental Material]
   793 E C1442792:State [Functional Concept]
   793 E C3148680:State [Geographic Area]
Processing 00000000.tx.125: Am J Clin Nutr 42:1318, 1985[Abstract] 3. 

Phrase: "Am"

Phrase: "J Clin Nutr 42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "1318,"

Phrase: "1985"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.126: Dallman PR, Yip R: Changing characteristics of childhood anemia (special article). 

Phrase: "Dallman PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Yip R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Changing characteristics of childhood anemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "(special article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706852:Article [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.127: J Pediatr 114:161, 1989[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "J Pediatr 114"

Phrase: ":"

Phrase: "161,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.128: Hallberg L, Hulten L, Lindstedt G, Lundberg P-A, Mark A, Purens J, Svanberg B, Swolin B: Prevalence of iron deficiency in Swedish adolescents. 

Phrase: "Hallberg L,"

Phrase: "Hulten L,"

Phrase: "Lindstedt G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lundberg P-A,"

Phrase: "Mark A,"

Phrase: "Purens J,"

Phrase: "Svanberg B,"

Phrase: "Swolin B"

Phrase: ":"

Phrase: "Prevalence of iron deficiency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]

Phrase: "in Swedish adolescents."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205653:Adolescents [Age Group]
Processing 00000000.tx.129: Pediatr Res 34:680, 1993[Abstract] 5. 

Phrase: "Pediatr Res 34"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "680,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.130: Hallberg L, Bengtsson C, Lapidus L, Lindstedt G, Lundberg P-A, Hulten L: Screening for iron deficiency: An analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. 

Phrase: "Hallberg L,"

Phrase: "Bengtsson C,"

Phrase: "Lapidus L,"

Phrase: "Lindstedt G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lundberg P-A,"

Phrase: "Hulten L"

Phrase: ":"

Phrase: "Screening for iron deficiency"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0420029:screening for iron deficiency [Finding]
           screening iron deficiency
   881   C1533631:Iron deficiency screening [Diagnostic Procedure]
   833   C0240066:Iron deficiency [Disease or Syndrome]
   770   C0011155:Deficiency [Functional Concept]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C0220908:Screening [Health Care Activity]
   770   C0220909:screening [Functional Concept]
   770   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0376520:Iron [Inorganic Chemical]
   770   C1166521:iron [Pharmacologic Substance]
   770   C1623416:deficiency [Qualitative Concept]
   770   C1698960:screening [Intellectual Product]
   770   C1710031:Screening [Diagnostic Procedure]
   770   C1710477:SCREENING [Research Activity]
   737 E C1305399:screen [Functional Concept]
   737 E C1705053:Screen [Medical Device]

Phrase: ":"

Phrase: "An analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "based on bone-marrow examinations"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   862   C0005957:Examinations, Bone Marrow [Laboratory Procedure]
   806   C0005953:Bone Marrow [Tissue]
   770 E C1708973:Medullary Bone [Tissue]
   760   C0031809:examinations [Health Care Activity]
   760   C0086590:Marrow [Food]
   760   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   760   C0376152:Marrow [Body Part, Organ, or Organ Component]
   760   C0391978:Bone [Tissue]
   760   C1266908:Bone [Body Part, Organ, or Organ Component]
   760   C1266909:Bone [Body System]
   760   C1527178:Based [Functional Concept]
   760   C1546708:Marrow [Intellectual Product]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]
   704 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   704 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   704 E C1550278:Medullary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "serum ferritin determinations in a population sample of women."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0680730:determinations [Governmental or Regulatory Activity]
   708 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.131: Br J Haematol 85:787, 1993[Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "Br J Haematol 85"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "787,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.132: Holyoake TL, Stott DJ, McKay PJ, Hendry A, MacDonald JB, Lucie NP: Use of plasma ferritin concentration to diagnose iron deficiency in elderly patients. 

Phrase: "Holyoake TL,"

Phrase: "Stott DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "McKay PJ,"

Phrase: "Hendry A,"

Phrase: "MacDonald JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Lucie NP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706141:NP [Gene or Genome]

Phrase: ":"

Phrase: "Use of plasma ferritin concentration to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "diagnose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:diagnose [Finding]

Phrase: "iron deficiency in elderly patients."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0240066:Iron deficiency [Disease or Syndrome]
   760   C0011155:Deficiency [Functional Concept]
   760   C0162429:Deficiency [Disease or Syndrome]
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1623416:deficiency [Qualitative Concept]
Processing 00000000.tx.133: J Clin Pathol 46:857, 1993[Abstract] 7. 

Phrase: "J Clin Pathol 46"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "857,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 7."
Processing 00000000.tx.134: Withold W, Neumayer C, Beyrau R, Heins M, Schauseil S, Rick W: Efficacy of transferrin determination in human sera in the diagnosis of iron deficiency. 

Phrase: "Withold W,"

Phrase: "Neumayer C,"

Phrase: "Beyrau R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Heins M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schauseil S,"

Phrase: "Rick W"

Phrase: ":"

Phrase: "Efficacy of transferrin determination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:Efficacy [Qualitative Concept]
   770   C1707887:EFFICACY [Research Activity]

Phrase: "in human sera"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0086418:Human [Human]
   861   C0229671:Sera [Body Substance]
   861   C1151254:SerA [Molecular Function]
   827 E C1546774:Serum [Intellectual Product]
   827 E C1550100:Serum [Body Substance]

Phrase: "in the diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "of iron deficiency."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0240066:Iron deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.135: Eur J Clin Chem Clin Biochem 32:19, 1994[Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "Eur J Clin Chem Clin Biochem 32"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0201682:CHEM [Laboratory Procedure]
   795   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "19,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.136: Bruner A, Joffe A, Duggan A, Casella J, Brandt J: Randomised study of cognitive effects of iron supplementation in non-anemic iron-deficient adolescent girls. 

Phrase: "Bruner"

Phrase: "A,"

Phrase: "Joffe A,"

Phrase: "Duggan A,"

Phrase: "Casella J,"

Phrase: "Brandt J"

Phrase: ":"

Phrase: "Randomised study of cognitive effects of iron supplementation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: "in non-anemic iron-deficient adolescent girls."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001588:Adolescent girls [Age Group]
   799   C0870604:girls [Age Group]
Processing 00000000.tx.137: Lancet 348:992, 1996[Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "Lancet 348"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "992,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.138: Bonkovsky H, Ponka P, Bacon B, Drysdale J, Grace N, Tavill A: An update on iron metabolism: Summary of the Fifth International Conference on Disorders of Iron Metabolism. 

Phrase: "Bonkovsky H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ponka P,"

Phrase: "Bacon B,"

Phrase: "Drysdale J,"

Phrase: "Grace N,"

Phrase: "Tavill A"

Phrase: ":"

Phrase: "An update on iron metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1519814:Update [Temporal Concept]

Phrase: ":"

Phrase: "Summary of the Fifth International Conference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552616:summary [Intellectual Product]
   753   C1706244:Summary [Intellectual Product]

Phrase: "on Disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]

Phrase: "of Iron Metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596803:iron metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.139: Hepatology 24:718, 1996[Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "Hepatology 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0086403:Hepatology [Biomedical Occupation or Discipline]
   861   C1555763:Hepatology [Professional or Occupational Group]

Phrase: ":"

Phrase: "718,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.140: Cook JD, Finch CA: Assessing iron status of a population. 

Phrase: "Cook JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Finch CA"

Phrase: ":"

Phrase: "Assessing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516048:Assess [Activity]

Phrase: "iron status of a population."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.141: Am J Clin Nutr 32:2115, 1979[Abstract] 11. 

Phrase: "Am"

Phrase: "J Clin Nutr 32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "2115,"

Phrase: "1979"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 11."
Processing 00000000.tx.142: Cook JD: Clinical evaluation of iron deficiency. 

Phrase: "Cook JD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: ":"

Phrase: "Clinical evaluation of iron deficiency."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1261322:Clinical evaluation [Health Care Activity]
           Evaluation
   806   C1516634:Clinical Evaluation [Research Activity]
   760   C0220825:Evaluation [Functional Concept]
Processing 00000000.tx.143: Semin Hematol 19:6, 1982[Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "Semin Hematol 19"

Phrase: ":"

Phrase: "6,"

Phrase: "1982"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.144: Hastka J, Lasserre J-J, Schwarzbeck A, Reiter A, Hehlmann R: Laboratory tests of iron status: Correlation or common sense? 

Phrase: "Hastka J,"

Phrase: "Lasserre J-J,"

Phrase: "Schwarzbeck A,"

Phrase: "Reiter A,"

Phrase: "Hehlmann R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Laboratory tests of iron status"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0022885:Laboratory Tests [Laboratory Procedure]
           Tests
   797   C0420636:status tests [Functional Concept]
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C0392366:Tests [Intellectual Product]
   760   C3244292:laboratory [Functional Concept]
   726 E C0039593:Test [Functional Concept]

Phrase: ":"

Phrase: "Correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlation [Qualitative Concept]

Phrase: "or"

Phrase: "common sense?"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036658:sense [Organ or Tissue Function]
   861   C0205214:Common [Quantitative Concept]
   861   C1522138:Common [Functional Concept]
   861   C3245511:common [Intellectual Product]
Processing 00000000.tx.145: Clin Chem 42:718, 1996[Abstract/Free FullText] 13. 

Phrase: "Clin Chem 42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0201682:CHEM [Laboratory Procedure]
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "718,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.146: Brittenham GM: Disorders of iron metabolism: Iron deficiency and iron overload , in Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (eds): Hematology, Basic Principles and Practice New York, NY, Churchill Livingstone , 1995 , p 492 14. 

Phrase: "Brittenham GM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: ":"

Phrase: "Disorders of iron metabolism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0012715:DISORDERS OF IRON METABOLISM [Disease or Syndrome]
           Iron Metabolism Disorders
           disorders iron
   870   C0025517:Disorder of metabolism NOS [Disease or Syndrome]
           Metabolism disorder NOS
   770   C0012634:Disorders [Disease or Syndrome]

Phrase: ":"

Phrase: "Iron deficiency"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0240066:Iron deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "and"

Phrase: "iron overload ,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0282193:Iron Overload [Disease or Syndrome]
  1000   C1963148:Iron overload [Finding]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "in Hoffman R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Benz EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Shattil SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Furie B,"

Phrase: "Cohen HJ,"

Phrase: "Silberstein LE (eds"

Phrase: ")"

Phrase: ":"

Phrase: "Hematology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
  1000   C0200627:HEMATOLOGY [Laboratory Procedure]
   928 E C0205488:Haematologic [Functional Concept]

Phrase: "Basic Principles"

Phrase: "and"

Phrase: "Practice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237607:practice [Mental Process]
  1000   C3245512:practice [Intellectual Product]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: "Churchill Livingstone ,"

Phrase: "1995 ,"

Phrase: "p 492 14."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.147: Skikne BS, Flowers CH, Cook JD: Serum transferrin receptor: A quantitative measure of tissue iron deficiency. 

Phrase: "Skikne BS,"

Phrase: "Flowers CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Cook JD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: ":"

Phrase: "Serum transferrin receptor"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "A quantitative measure of tissue iron deficiency."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079809:Measure [Quantitative Concept]
   748   C0242485:Measure [Functional Concept]
Processing 00000000.tx.148: Blood 75:1870, 1990[Abstract] 15. 

Phrase: "Blood 75"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "1870,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 15."
Processing 00000000.tx.149: Baynes RD: Refining the assessment of body iron status (editorial). 

Phrase: "Baynes RD"

Phrase: ":"

Phrase: "Refining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   907   C1947930:Cleanse [Activity]
   907   C1998793:Purified [Functional Concept]

Phrase: "the assessment of body iron status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261322:Assessment [Health Care Activity]
   753   C1516048:Assessment [Activity]

Phrase: "(editorial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282412:Editorial [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.150: Am J Clin Nutr 64:793, 1996[Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "Am"

Phrase: "J Clin Nutr 64"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "793,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.151: Punnonen K, Irjala K, Rajamki A: Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. 

Phrase: "Punnonen K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Irjala K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Rajamki A"

Phrase: ":"

Phrase: "Serum transferrin receptor"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "its ratio to serum ferritin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "in the diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "of iron deficiency."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0240066:Iron deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.152: Blood 89:1052, 1997[Abstract/Free FullText] 17. 

Phrase: "Blood 89"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "1052,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.153: Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD: Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. 

Phrase: "Ferguson BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Skikne BS,"

Phrase: "Simpson KM,"

Phrase: "Baynes RD,"

Phrase: "Cook JD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: ":"

Phrase: "Serum transferrin receptor"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "distinguishes"

Phrase: "the anemia of chronic disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   926   C0002873:Anaemia of chronic disease [Disease or Syndrome]
           anaemia chronic disease
   797   C0581384:Chronic anaemia [Disease or Syndrome]
   760   C0002871:Anaemia [Disease or Syndrome]
   760   C1000483:Anemia [Plant]

Phrase: "from iron deficiency anemia."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   901   C0041782:Deficiency Anemia [Disease or Syndrome]
   901   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0002871:Anaemia [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1000483:Anemia [Plant]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C0857322:anaemic [Finding]
   755 E C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.154: J Lab Clin Med 119:385, 1992[Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "J Lab Clin Med 119"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0022877:Lab [Manufactured Object,Organization]
   804   C1315013:CLIN [Intellectual Product]
   748 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   721 E C0587081:Labs [Finding]

Phrase: ":"

Phrase: "385,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.155: Punnonen K, Irjala K, Rajamki A: Iron deficiency anemia is associated with high serum levels of transferrin receptor. 

Phrase: "Punnonen K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Irjala K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Rajamki A"

Phrase: ":"

Phrase: "Iron deficiency anemia"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   901   C0041782:Deficiency Anemia [Disease or Syndrome]
   901   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0002871:Anaemia [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1000483:Anemia [Plant]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C0857322:anaemic [Finding]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "is"

Phrase: "associated with high serum levels of transferrin receptor."
Meta Candidates (Total=24; Excluded=6; Pruned=0; Remaining=18)
   770   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   770   C1619635:Transferrin Receptor [Immunologic Factor]
   767   C0427432:levels transferrin [Laboratory or Test Result]
   767   C0428545:Serum transferrin [Laboratory Procedure]
   767   C1318186:serum transferrin [Laboratory or Test Result]
   750 E C0202105:Transferrin level [Laboratory Procedure]
   744   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205250:High [Qualitative Concept]
   744   C0229671:Serum [Body Substance]
   744   C0441889:Levels [Qualitative Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1299351:High [Qualitative Concept]
   744   C1442762:TRANSFERRIN [Gene or Genome]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   744   C2700149:HIGH [Intellectual Product]
   711 E C0456079:Level [Classification]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1547707:Level [Geographic Area]
   711 E C1706221:Associate [Professional or Occupational Group]
   711 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.156: Clin Chem 40:774, 1994[Abstract/Free FullText] 19. 

Phrase: "Clin Chem 40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0201682:CHEM [Laboratory Procedure]
   827   C0439509:/40 [Temporal Concept]
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "774,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] 19."
Processing 00000000.tx.157: Suominen P, Punnonen K, Rajamki A, Irjala K: The evaluation of new immunoenzymometric assay for measuring soluble transferrin receptor to detect iron deficiency in anemic patients. 

Phrase: "Suominen P,"

Phrase: "Punnonen K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Rajamki A,"

Phrase: "Irjala K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "The evaluation of new immunoenzymometric assay"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "for measuring soluble transferrin receptor to"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   884   C1116139:soluble transferrin receptor [Body Substance]
   884   C3541318:Soluble Transferrin Receptor [Laboratory Procedure]
   840   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   840   C1619635:Transferrin Receptor [Immunologic Factor]
   804   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1442762:TRANSFERRIN [Gene or Genome]
   721 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "iron deficiency in anemic patients."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0240066:Iron deficiency [Disease or Syndrome]
   760   C0011155:Deficiency [Functional Concept]
   760   C0162429:Deficiency [Disease or Syndrome]
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1623416:deficiency [Qualitative Concept]
Processing 00000000.tx.158: Clin Chem 43:1641, 1997[Abstract/Free FullText] 20. 

Phrase: "Clin Chem 43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0201682:CHEM [Laboratory Procedure]
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "1641,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.159: Flowers CH, Skikne BS, Covell AM, Cook JD: The clinical measurement of serum transferrin receptor. 

Phrase: "Flowers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0330090:Flower [Plant]
  1000   C1413035:FLOWER [Gene or Genome]

Phrase: "CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0558269:Ch. [Professional or Occupational Group]
  1000   C1552984:[Ch] [Quantitative Concept]

Phrase: "Skikne BS,"

Phrase: "Covell"

Phrase: "AM"

Phrase: ","

Phrase: "Cook JD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: ":"

Phrase: "The clinical measurement of serum transferrin receptor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0428545:Serum transferrin measurement [Laboratory Procedure]
   778   C0947289:clinical measurement [Health Care Activity]
   774   C0202105:Transferrin measurement [Laboratory Procedure]
   748   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.160: J Lab Clin Med 114:368, 1989[Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "J Lab Clin Med 114"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0022877:Lab [Manufactured Object,Organization]
   804   C1315013:CLIN [Intellectual Product]
   748 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   721 E C0587081:Labs [Finding]

Phrase: ":"

Phrase: "368,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.161: Sohlberg HE: Approved recommendation (1986) on the theory of reference values. 

Phrase: "Sohlberg"

Phrase: "HE"

Phrase: ":"

Phrase: "Approved recommendation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034866:Recommendation [Idea or Concept]

Phrase: "(1986"

Phrase: ")"

Phrase: "on the theory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871935:Theory [Idea or Concept]

Phrase: "of reference values."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0086715:Reference Values [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   861   C1514811:Reference [Idea or Concept]
   861   C1706462:Reference [Conceptual Entity]
   827 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.162: Part 1.

Phrase: "Part 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449719:Part [Spatial Concept]
   861   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.163: The concept of reference values. 

Phrase: "The concept of reference values."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0178566:concept [Idea or Concept]
Processing 00000000.tx.164: J Clin Chem Clin Biochem 25:337, 1987[Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "J Clin Chem Clin Biochem 25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0201682:CHEM [Laboratory Procedure]
   799   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "337,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.165: National Committee for Clinical Laboratory Standards: How to define and determine reference intervals in the clinical laboratory; 

Phrase: "National Committee for Clinical Laboratory Standards"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   799   C0022877:Laboratory [Manufactured Object,Organization]
   799   C0038137:standards [Intellectual Product]
   799   C0175675:Standards [Qualitative Concept]
   799   C0205210:Clinical [Qualitative Concept]
   799   C2699414:Committee [Group]
   799   C3244292:laboratory [Functional Concept]
   799   C3245503:national [Intellectual Product]
   766 E C1442989:Standard [Qualitative Concept]
   766 E C2828392:Standard [Intellectual Product]

Phrase: ":"

Phrase: "How to"

Phrase: "define"

Phrase: "and"

Phrase: "determine"

Phrase: "reference intervals in the clinical laboratory"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   783   C1532342:Reference laboratory [Quantitative Concept]
   756   C0086715:reference interval [Quantitative Concept]
   753   C1272706:intervals [Temporal Concept]
   753   C1514811:Reference [Idea or Concept]
   753   C1706462:Reference [Conceptual Entity]
   719 E C1552654:Interval [Idea or Concept]
   719 E C1552713:Interval [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.166: Approved guideline. 

Phrase: "Approved guideline."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0162791:Guideline [Intellectual Product]
   861   C0282423:Guideline [Intellectual Product]
Processing 00000000.tx.167: National Committee for Clinical Laboratory Standards Document C28-A 15:15, 1995 23. 

Phrase: "National Committee for Clinical Laboratory Standards"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   799   C0022877:Laboratory [Manufactured Object,Organization]
   799   C0038137:standards [Intellectual Product]
   799   C0175675:Standards [Qualitative Concept]
   799   C0205210:Clinical [Qualitative Concept]
   799   C2699414:Committee [Group]
   799   C3244292:laboratory [Functional Concept]
   799   C3245503:national [Intellectual Product]
   766 E C1442989:Standard [Qualitative Concept]
   766 E C2828392:Standard [Intellectual Product]

Phrase: "Document"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1301746:document [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]

Phrase: "C28-"

Phrase: "A 15"

Phrase: ":"

Phrase: "15,"

Phrase: "1995 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.168: Garby L, Irnell L, Werner I: Iron deficiency in women of fertile age in a Swedish community. 

Phrase: "Garby L,"

Phrase: "Irnell L,"

Phrase: "Werner I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "Iron deficiency in women of fertile age"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0240066:Iron deficiency [Disease or Syndrome]
   748   C0011155:Deficiency [Functional Concept]
   748   C0162429:Deficiency [Disease or Syndrome]
   748   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0376520:Iron [Inorganic Chemical]
   748   C1166521:iron [Pharmacologic Substance]
   748   C1623416:deficiency [Qualitative Concept]

Phrase: "in a Swedish community."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009462:Community [Geographic Area]
Processing 00000000.tx.169: Acta Med Scand 185:113, 1969[Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "Acta Med Scand 185"

Phrase: ":"

Phrase: "113,"

Phrase: "1969"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.170: van Zeben D, Bieger R, van Wermeskerken RKA, Castel A, Hermans J: Evaluation of microcytosis using serum ferritin and red blood cell distribution width. 

Phrase: "van Zeben D,"

Phrase: "Bieger R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "van Wermeskerken RKA,"

Phrase: "Castel A,"

Phrase: "Hermans J"

Phrase: ":"

Phrase: "Evaluation of microcytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0220825:Evaluation [Functional Concept]
   790   C1261322:Evaluation [Health Care Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "serum ferritin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0696113:Serum ferritin [Laboratory Procedure]
   861   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "red blood cell distribution width."
Meta Candidates (Total=25; Excluded=9; Pruned=0; Remaining=16)
   933   C0427460:Red Cell Distribution Width [Laboratory Procedure]
   884   C0014792:Red blood cell [Cell]
           Red Cell
   840   C0005773:Blood cell [Cell]
   812 E C2328697:Hemal cell [Cell]
   804   C0005767:Blood [Tissue]
   804   C0005768:blood [Body Substance]
   804   C0007634:Cell [Cell]
   804   C0229664:Blood [Body Substance]
   804   C0332575:Red [Finding]
   804   C0487742:Width [Quantitative Concept]
   804   C0520511:distribution [Idea or Concept]
   804   C1260956:Red [Qualitative Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1704711:Distribution [Functional Concept]
   804   C1948049:Cell [Spatial Concept]
   733 E C0332464:Wide [Spatial Concept]
   733 E C0333275:Bloody [Qualitative Concept]
   721 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   721 E C0392895:Bloods [Population Group]
   721 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   721 E C1511228:VESSEL, BLOOD [Tissue]
   704 E C1558950:VASCULAR [Finding]
   704 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.171: Eur J Haematol 44:105, 1990 25. 

Phrase: "Eur J Haematol 44"

Phrase: ":"

Phrase: "105,"

Phrase: "1990 25."
Processing 00000000.tx.172: Baynes RD: Assessment of iron status (review). 

Phrase: "Baynes RD"

Phrase: ":"

Phrase: "Assessment of iron status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261322:Assessment [Health Care Activity]
   770   C1516048:Assessment [Activity]

Phrase: "(review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.173: Clin Biochem 29:209, 1996[Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "Clin Biochem 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "209,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.174: Huebers HA, Finch CA: The physiology of transferrin and transferrin receptors. 

Phrase: "Huebers HA,"

Phrase: "Finch CA"

Phrase: ":"

Phrase: "The physiology of transferrin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031842:Physiology [Biomedical Occupation or Discipline]
   770   C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "transferrin receptors."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0034845:Receptors, Transferrin [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   966 E C1619635:Transferrin Receptor [Immunologic Factor]
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.175: Physiol Rev 67:520, 1987[Free FullText] 27. 

Phrase: "Physiol Rev 67"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "520,"

Phrase: "1987"

Phrase: "[Free FullText"

Phrase: "] 27."
Processing 00000000.tx.176: Kairisto V, Poola A: Software for illustrative presentation of basic clinical characteristics of laboratory tests GraphROC for Windows. 

Phrase: "Kairisto V,"

Phrase: "Poola A"

Phrase: ":"

Phrase: "Software for illustrative presentation of basic clinical characteristics of laboratory tests GraphROC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "for Windows."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557702:windows [Manufactured Object]
   966 E C1272706:Window [Temporal Concept]
   966 E C1704674:Window [Manufactured Object]
Processing 00000000.tx.177: Scand J Clin Lab Invest Suppl 222:43, 1995[Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "Scand J Clin Lab"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0022877:Lab [Manufactured Object,Organization]
   756 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   729 E C0587081:Labs [Finding]

Phrase: "Invest"

Phrase: "Suppl 222"

Phrase: ":"

Phrase: "43,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.178: Guyatt GH, Oxman AD, Mahmoud A, Willan A, McIlroy W: Laboratory diagnosis of iron deficiency anemia: An overview. 

Phrase: "Guyatt GH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033993:GH [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539616:GH [Gene or Genome]

Phrase: "Oxman AD,"

Phrase: "Mahmoud A,"

Phrase: "Willan A,"

Phrase: "McIlroy W"

Phrase: ":"

Phrase: "Laboratory diagnosis of iron deficiency anemia"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0011911:Laboratory Diagnosis [Diagnostic Procedure]
   753   C0011900:Diagnosis [Finding]
   753   C0022877:Laboratory [Manufactured Object,Organization]
   753   C1704338:diagnosis [Qualitative Concept]
   753   C1704656:DIAGNOSIS [Research Activity]
   753   C3244292:laboratory [Functional Concept]

Phrase: ":"

Phrase: "An overview."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0814812:overview [Intellectual Product]
Processing 00000000.tx.179: J Gen Intern Med 7:145, 1992[Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "J Gen Intern Med 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1144859:INTERN [Professional or Occupational Group]
   804   C1704351:GEN [Quantitative Concept]
   804   C2239486:Gen [Gene or Genome]

Phrase: ":"

Phrase: "145,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.180: Cook JD, Lynch SR: The liabilities of iron deficiency (review). 

Phrase: "Cook JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Lynch SR"

Phrase: ":"

Phrase: "The liabilities of iron deficiency"

Phrase: "(review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.181: Blood 68:803, 1986[Abstract] 30. 

Phrase: "Blood 68"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0450387:68 [Intellectual Product]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "803,"

Phrase: "1986"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 30."
Processing 00000000.tx.182: Lee RG: Iron deficiency and iron-deficiency anemia , in Lee RG, Bithell TC, Foerster J, Athens JW, Lukens JN (eds): Wintrobe's Clinical Hematology, (vol 1,ed 9). 

Phrase: "Lee RG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: ":"

Phrase: "Iron deficiency"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0240066:Iron deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "and"

Phrase: "iron-deficiency anemia ,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   901   C0041782:Deficiency Anemia [Disease or Syndrome]
   901   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0002871:Anaemia [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1000483:Anemia [Plant]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C0857322:anaemic [Finding]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "in Lee RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Bithell TC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041405:TC [Geographic Area]
   861   C1824670:TC [Gene or Genome]
   861   C3272447:TC [Gene or Genome]

Phrase: "Foerster J,"

Phrase: "Athens JW,"

Phrase: "Lukens JN (eds"

Phrase: ")"

Phrase: ":"

Phrase: "Wintrobe's Clinical Hematology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1274118:Clinical haematology [Biomedical Occupation or Discipline]
   827   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   827   C0200627:HEMATOLOGY [Laboratory Procedure]
   755 E C0205488:Haematologic [Functional Concept]

Phrase: "(vol 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449468:VOL [Quantitative Concept]
   861   C0560268:vol% [Quantitative Concept]
   861   C1690016:% vol [Qualitative Concept]

Phrase: "ed 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.183: Philadelphia, PA, Lea &Febiger , 1993 , p 808 31. 

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "Lea &Febiger ,"

Phrase: "1993 ,"

Phrase: "p 808 31."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0450355:31 [Intellectual Product]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.184: Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA: Intact transferrin receptors in human plasma and their relation to erythropoiesis. 

Phrase: "Huebers HA,"

Phrase: "Beguin Y,"

Phrase: "Pootrakul P,"

Phrase: "Einspahr D,"

Phrase: "Finch CA"

Phrase: ":"

Phrase: "Intact transferrin receptors in human plasma"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0034845:Receptors, Transferrin [Amino Acid, Peptide, or Protein,Receptor]
   756 E C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   756 E C1619635:Transferrin Receptor [Immunologic Factor]
   753   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   753   C1442762:TRANSFERRIN [Gene or Genome]

Phrase: "and"

Phrase: "their relation to erythropoiesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0080103:Relation [Family Group]
   770   C0869014:relation [Social Behavior]
Processing 00000000.tx.185: Blood 75:102, 1990[Abstract] 32. 

Phrase: "Blood 75"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "102,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 32."
Processing 00000000.tx.186: Cook JD, Lipschitz DA, Laughton EMM, Finch CA: Serum ferritin as a measure of iron stores in normal subjects. 

Phrase: "Cook JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Lipschitz DA,"

Phrase: "Laughton EMM,"

Phrase: "Finch CA"

Phrase: ":"

Phrase: "Serum ferritin as a measure of iron"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0696113:Serum ferritin [Laboratory Procedure]
   774   C1318312:iron serum [Laboratory Procedure]
   748   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0229671:Serum [Body Substance]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]

Phrase: "stores in normal subjects."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1698986:Store [Functional Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.187: Am J Clin Nutr 27:681, 1974[Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "Am"

Phrase: "J Clin Nutr 27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "681,"

Phrase: "1974"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.188: Looker AC, Gunter EW, Cook JD, Green R, Harris JW: Comparing serum ferritin values from different population surveys. 

Phrase: "Looker AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Gunter EW,"

Phrase: "Cook JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Green R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Harris JW"

Phrase: ":"

Phrase: "Comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "serum ferritin values from different population surveys."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.189: Vital Health Stat 2 111:1, 1991[Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "Vital Health Stat 2 111"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   875   C1120833:Vital-2 [Organic Chemical,Pharmacologic Substance]
   804   C0018684:Health [Idea or Concept]
   804   C0205548:Stat [Temporal Concept]
   804   C0442732:Vital [Qualitative Concept]
   804   C1875856:VITAL [Food]
   704 E C0031206:healthiness [Finding]

Phrase: ":"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.190: Vicente C, Porto G, de Sousa M: Method for establishing serum ferritin reference values depending on sex and age. 

Phrase: "Vicente C,"

Phrase: "Porto G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "de Sousa M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Method for establishing serum ferritin reference values"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "depending on sex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0009253:Sex [Organism Function]
   790   C0036864:Sex [Behavior]
   790   C0079399:sex [Organism Attribute]
   790   C1314687:Sex [Finding]
   790   C1522384:sex [Organism Attribute]
   756   C0725813:depend [Medical Device]

Phrase: "and"

Phrase: "age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.191: Clin Med 116:779, 1990 35. 

Phrase: "Clin Med 116"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "779,"

Phrase: "1990 35."
Processing 00000000.tx.192: Wheby MS: Effect of iron therapy on serum ferritin levels in iron-deficiency anemia. 

Phrase: "Wheby MS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: ":"

Phrase: "Effect of iron therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1518681:Therapy Effect [Finding]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on serum ferritin levels"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   966   C0696113:Serum ferritin level [Laboratory Procedure]
           Serum ferritin
   901   C0427405:ferritin levels [Laboratory or Test Result]
   867 E C0373607:Ferritin level [Laboratory Procedure]
   827   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0229671:Serum [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "in iron-deficiency anemia."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0162316:Iron deficiency anaemia [Disease or Syndrome]
   901   C0041782:Deficiency Anemia [Disease or Syndrome]
   901   C0240066:Iron deficiency [Disease or Syndrome]
   827   C0002871:Anaemia [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1000483:Anemia [Plant]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C0857322:anaemic [Finding]
   755 E C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.193: Blood 56:138, 1980[Abstract] 36. 

Phrase: "Blood 56"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "138,"

Phrase: "1980"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 36."
Processing 00000000.tx.194: Simmons WK, Cook JD, Bingham KC, Thomas M, Jackson J, Jackson M, Ahluwalia N, Kahn SG, Patterson AW: Evaluation of a gastric delivery system for iron supplementation in pregnancy. 

Phrase: "Simmons WK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/wk [Temporal Concept]
   861   C0439230:wk [Temporal Concept]

Phrase: "Cook JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Bingham KC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022575:kc [Disease or Syndrome]
   861   C1705783:KC [Gene or Genome]

Phrase: "Thomas M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Jackson J,"

Phrase: "Jackson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ahluwalia N,"

Phrase: "Kahn SG,"

Phrase: "Patterson AW"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: ":"

Phrase: "Evaluation of a gastric delivery system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "for iron supplementation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242297:Supplementation [Therapeutic or Preventive Procedure]

Phrase: "in pregnancy."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]
Processing 00000000.tx.195: Am J Clin Nutr 58:622, 1993[Abstract] 37. 

Phrase: "Am"

Phrase: "J Clin Nutr 58"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "622,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 37."
Processing 00000000.tx.196: Cavill I, Jacobs A, Worwood M: Diagnostic methods for iron status (review). 

Phrase: "Cavill I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jacobs A,"

Phrase: "Worwood M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Diagnostic methods for iron status"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0430022:Diagnostic Method [Diagnostic Procedure]
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "(review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.197: Ann Clin Biochem 23:168, 1986[Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "Ann Clin Biochem 23"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450348:23 [Quantitative Concept]
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "168,"

Phrase: "1986"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.198: Blake DR, Waterworth RF, Bacon PA: Assessment of iron stores in inflammation by assays of serum ferritin concentrations. 

Phrase: "Blake DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Waterworth RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: "Bacon PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: ":"

Phrase: "Assessment of iron"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1261322:Assessment [Health Care Activity]
   790   C1516048:Assessment [Activity]

Phrase: "stores in inflammation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021368:Inflammation [Pathologic Function]
   790   C1698986:Store [Functional Concept]

Phrase: "by assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "of serum ferritin concentrations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   896   C0683149:serum concentration [Quantitative Concept]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0696113:Serum ferritin [Laboratory Procedure]
Processing 00000000.tx.199: BMJ 283:1147, 1981[Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "BMJ 283"

Phrase: ":"

Phrase: "1147,"

Phrase: "1981"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.200: Burns ER, Goldberg NS, Lawrence C, Wenz B: Clinical utility of serum tests for iron deficiency in hospitalized patients. 

Phrase: "Burns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006434:Burn [Injury or Poisoning]
  1000   C1550619:Burn [Substance]

Phrase: "ER,"

Phrase: "Goldberg NS,"

Phrase: "Lawrence C,"

Phrase: "Wenz B"

Phrase: ":"

Phrase: "Clinical utility of serum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0582205:utility [Organization]

Phrase: "tests for iron deficiency"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0240066:Iron deficiency [Disease or Syndrome]
   770   C0011155:Deficiency [Functional Concept]
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0376520:Iron [Inorganic Chemical]
   770   C0392366:Tests [Intellectual Product]
   770   C1166521:iron [Pharmacologic Substance]
   770   C1623416:deficiency [Qualitative Concept]

Phrase: "in hospitalized patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870668:hospitalized patients [Patient or Disabled Group]
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.201: Am J Clin Pathol 93:240, 1990[Medline] [OrderarticleviaInfotrieve] 40. 

Phrase: "Am"

Phrase: "J Clin Pathol 93"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "240,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.202: Coenen JLLM, van Dieijen-Visser MP, van Pelt J, van Deursen CTBM, Fickers MMF, van Wersch JWJ, Brombacher PJ: Measurement of serum ferritin used to predict concentrations of iron in bone marrow in anemia of chronic disease. 

Phrase: "Coenen JLLM,"

Phrase: "van Dieijen-Visser MP,"

Phrase: "van"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0557775:Van [Manufactured Object]

Phrase: "Pelt"

Phrase: "J,"

Phrase: "van Deursen CTBM,"

Phrase: "Fickers MMF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0083765:MMF [Therapeutic or Preventive Procedure]
   861   C0209368:MMF [Organic Chemical,Pharmacologic Substance]

Phrase: "van Wersch JWJ,"

Phrase: "Brombacher PJ"

Phrase: ":"

Phrase: "Measurement of serum ferritin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C0696113:Serum ferritin measurement [Laboratory Procedure]
   819   C0373607:Ferritin measurement [Laboratory Procedure]
   770   C0242485:Measurement [Functional Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "predict"

Phrase: "concentrations of iron"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0086045:Concentrations [Mental Process]
   756 E C1446561:Concentration [Quantitative Concept]
   706 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in bone marrow"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
  1000   C0005953:Bone Marrow [Tissue]
   861   C0086590:Marrow [Food]
   861   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   861   C0376152:Marrow [Body Part, Organ, or Organ Component]
   861   C0391978:Bone [Tissue]
   861   C1266908:Bone [Body Part, Organ, or Organ Component]
   861   C1266909:Bone [Body System]
   861   C1546708:Marrow [Intellectual Product]
   805 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   805 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   805 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   789 E C0443157:Bony [Functional Concept]
   777 E C0330477:Marrows [Plant]

Phrase: "in anemia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0002871:Anaemia [Disease or Syndrome]
  1000   C1000483:Anemia [Plant]
   928 E C0857322:anaemic [Finding]

Phrase: "of chronic disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0008679:Chronic disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0205191:chronic [Temporal Concept]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.203: Clin Chem 37:560, 1991[Abstract/Free FullText] 41. 

Phrase: "Clin Chem 37"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0201682:CHEM [Laboratory Procedure]
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "560,"

Phrase: "1991"

Phrase: "[Abstract/Free FullText"

Phrase: "] 41."
Processing 00000000.tx.204: Witte DL, Angstadt DS, Davis SH, Schrantz RD: Predicting bone marrow iron stores in anemic patients in a community hospital using ferritin and erythrocyte sedimentation rate. 

Phrase: "Witte DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Angstadt DS,"

Phrase: "Davis SH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]

Phrase: "Schrantz RD"

Phrase: ":"

Phrase: "Predicting"

Phrase: "bone marrow iron"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1292130:Bone marrow iron [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]
   734   C0005953:Bone Marrow [Tissue]

Phrase: "stores in anemic patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0857322:anaemic [Finding]
   770   C1698986:Store [Functional Concept]

Phrase: "in a community hospital"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0020003:Community Hospital [Health Care Related Organization,Manufactured Object]
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ferritin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "erythrocyte sedimentation rate."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0086250:Erythrocyte Sedimentation Rate [Laboratory Procedure]
  1000   C1176468:Erythrocyte Sedimentation Rate [Laboratory Procedure]
           Sedimentation rate, NOS
  1000   C1619634:Erythrocyte Sedimentation Rate [Finding]
   901   C0005833:Erythrocyte Sedimentation [Laboratory Procedure]
   827   C0014792:Erythrocyte [Cell]
   827   C0597428:Sedimentation [Laboratory Procedure]
   827   C0871208:Rate [Activity]
   827   C1384604:Sedimentation [Natural Phenomenon or Process]
   827   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.205: Am J Clin Pathol 90:85, 1988[Medline] [OrderarticleviaInfotrieve] 42. 

Phrase: "Am"

Phrase: "J Clin Pathol 90"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "85,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 42."
Processing 00000000.tx.206: Kurer SB, Seifert B, Michel B, Ruegg R, Fehr J: Prediction of iron deficiency in chronic inflammatory rheumatic disease anemia. 

Phrase: "Kurer SB,"

Phrase: "Seifert B,"

Phrase: "Michel B,"

Phrase: "Ruegg R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Fehr J"

Phrase: ":"

Phrase: "Prediction of iron deficiency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0681842:Prediction [Idea or Concept]

Phrase: "in chronic inflammatory rheumatic disease anemia."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   911   C0002873:chronic disease anemia [Disease or Syndrome]
   897   C0581384:Chronic anaemia [Disease or Syndrome]
   804   C0002871:Anaemia [Disease or Syndrome]
   804   C1000483:Anemia [Plant]
   733 E C0857322:anaemic [Finding]
   722   C1290886:Chronic inflammatory disease [Disease or Syndrome]
   708   C0008679:Chronic disease [Disease or Syndrome]
Processing 00000000.tx.207: Br J Haematol 91:820, 1995[Medline] [OrderarticleviaInfotrieve] 43. 

Phrase: "Br J Haematol 91"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "820,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 43."
Processing 00000000.tx.208: Porter DR, Sturrock RD, Capell HA: The use of serum ferritin estimation in the investigation of anemia in patients with rheumatoid arthritis. 

Phrase: "Porter DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Sturrock RD,"

Phrase: "Capell HA"

Phrase: ":"

Phrase: "The use of serum ferritin estimation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "in the investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1261322:Investigation [Health Care Activity]
  1000   C1552578:investigation [Idea or Concept]
   928 E C1517586:Investigational [Qualitative Concept]
   928 E C3245491:investigational [Intellectual Product]

Phrase: "of anemia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0002871:Anaemia [Disease or Syndrome]
  1000   C1000483:Anemia [Plant]
   928 E C0857322:anaemic [Finding]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with rheumatoid arthritis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]
Processing 00000000.tx.209: Clin Exp Rheumatol 12:179, 1994[Medline] [OrderarticleviaInfotrieve] 44. 

Phrase: "Clin Exp Rheumatol 12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1315013:CLIN [Intellectual Product]
   812   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "179,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 44."
Processing 00000000.tx.210: Konijn AM, Hershko C: Ferritin synthesis in inflammation. 

Phrase: "Konijn"

Phrase: "AM"

Phrase: ","

Phrase: "Hershko C"

Phrase: ":"

Phrase: "Ferritin synthesis in inflammation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]
Processing 00000000.tx.211: Br J Haematol 37:7, 1977[Medline] [OrderarticleviaInfotrieve] 45. 

Phrase: "Br J Haematol 37"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "7,"

Phrase: "1977"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 45."
Processing 00000000.tx.212: Cooper MJ, Zlotkin SH: Day-to-day variation of transferrin receptor and ferritin in healthy men and women. 

Phrase: "Cooper MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Zlotkin SH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]

Phrase: ":"

Phrase: "Day-to-day variation of transferrin receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variation [Qualitative Concept]

Phrase: "and"

Phrase: "ferritin in healthy men"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]
Processing 00000000.tx.213: Am J Clin Nutr 64:738, 1996[Abstract] 46. 

Phrase: "Am"

Phrase: "J Clin Nutr 64"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "738,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 46."
Processing 00000000.tx.214: Cook JD, Skikne BS, Baynes RD: Serum transferrin receptor. 

Phrase: "Cook JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Skikne BS,"

Phrase: "Baynes RD"

Phrase: ":"

Phrase: "Serum transferrin receptor."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0034845:Transferrin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0428545:Serum transferrin [Laboratory Procedure]
   901   C1318186:serum transferrin [Laboratory or Test Result]
   901   C1420708:TRANSFERRIN RECEPTOR [Gene or Genome]
   901   C1619635:Transferrin Receptor [Immunologic Factor]
   827   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1442762:TRANSFERRIN [Gene or Genome]
   743 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.215: Annu Rev Med 44:63, 1993[Medline] [OrderarticleviaInfotrieve] 47. 

Phrase: "Annu Rev Med 44"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "63,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 47."
Processing 00000000.tx.216: Tietz NW, Rinker AD, Morrison SR: When is a serum iron really a serum iron? 

Phrase: "Tietz NW,"

Phrase: "Rinker AD,"

Phrase: "Morrison SR"

Phrase: ":"

Phrase: "When"

Phrase: "is"

Phrase: "a serum iron really"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1318312:serum iron [Laboratory Procedure]
   827   C0229671:Serum [Body Substance]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "a serum iron?"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1318312:serum iron [Laboratory Procedure]
   861   C0229671:Serum [Body Substance]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
Processing 00000000.tx.217: The status of serum iron measurements. 

Phrase: "The status of serum iron measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.218: Clin Chem 40:546, 1994[Abstract/Free FullText] 48. 

Phrase: "Clin Chem 40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0201682:CHEM [Laboratory Procedure]
   827   C0439509:/40 [Temporal Concept]
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "546,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] 48."
Processing 00000000.tx.219: Borel MJ, Smith SM, Derr J, Beard JL: Day-to-day variation in iron-status indices in healthy men and women. 

Phrase: "Borel MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Smith SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Derr J,"

Phrase: "Beard JL"

Phrase: ":"

Phrase: "Day-to-day variation in iron-status indices"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:Variation [Qualitative Concept]

Phrase: "in healthy men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0025266:Men [Population Group]
   827 E C0024554:MAN [Finding]
   827 E C0086418:Man [Human]

Phrase: "and"

Phrase: "women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]
Processing 00000000.tx.220: Am J Clin Nutr 54:729, 1991[Abstract]  1998 by the American Society of Hematology.  

Phrase: "Am"

Phrase: "J Clin Nutr 54"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "729,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]  1998 by the American Society of Hematology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1515949:American Society of Hematology [Professional Society]
   748   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   748   C0037455:society [Organization]
   748   C0200627:HEMATOLOGY [Laboratory Procedure]
   748   C0596070:American [Population Group]
Processing 00000000.tx.221: 0006-4971/98/92-0007$3.00/0

Phrase: "0006-4971/98/92-0007$3.00/0"

